Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Feb 14;18(2):e1010055. doi: 10.1371/journal.pgen.1010055

Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila

Dnyanesh Dubal 1,¤a, Prachiti Moghe 1,¤b,#, Rahul Kumar Verma 1,#, Bhavin Uttekar 1, Richa Rikhy 1,*
Editor: Hongyan Wang2
PMCID: PMC8880953  PMID: 35157701

Abstract

Optimal mitochondrial function determined by mitochondrial dynamics, morphology and activity is coupled to stem cell differentiation and organism development. However, the mechanisms of interaction of signaling pathways with mitochondrial morphology and activity are not completely understood. We assessed the role of mitochondrial fusion and fission in the differentiation of neural stem cells called neuroblasts (NB) in the Drosophila brain. Depleting mitochondrial inner membrane fusion protein Opa1 and mitochondrial outer membrane fusion protein Marf in the Drosophila type II NB lineage led to mitochondrial fragmentation and loss of activity. Opa1 and Marf depletion did not affect the numbers of type II NBs but led to a decrease in differentiated progeny. Opa1 depletion decreased the mature intermediate precursor cells (INPs), ganglion mother cells (GMCs) and neurons by the decreased proliferation of the type II NBs and mature INPs. Marf depletion led to a decrease in neurons by a depletion of proliferation of GMCs. On the contrary, loss of mitochondrial fission protein Drp1 led to mitochondrial clustering but did not show defects in differentiation. Depletion of Drp1 along with Opa1 or Marf also led to mitochondrial clustering and suppressed the loss of mitochondrial activity and defects in proliferation and differentiation in the type II NB lineage. Opa1 depletion led to decreased Notch signaling in the type II NB lineage. Further, Notch signaling depletion via the canonical pathway showed mitochondrial fragmentation and loss of differentiation similar to Opa1 depletion. An increase in Notch signaling showed mitochondrial clustering similar to Drp1 mutants. Further, Drp1 mutant overexpression combined with Notch depletion showed mitochondrial fusion and drove differentiation in the lineage, suggesting that fused mitochondria can influence differentiation in the type II NB lineage. Our results implicate crosstalk between proliferation, Notch signaling, mitochondrial activity and fusion as an essential step in differentiation in the type II NB lineage.

Author summary

Mitochondrial morphology and function are coupled to stem cell differentiation and organism development. It is of interest to examine the mechanisms of interaction of mitochondrial dynamics with signaling pathways during stem cell differentiation. We have assessed the role of mitochondrial fusion and fission in the differentiation of neural stem cells called neuroblasts (NB) in the Drosophila brain. Depleting mitochondrial fusion proteins Opa1 and Marf led to mitochondrial fragmentation, loss of mitochondrial activity and proliferation, thereby causing a decrease in the numbers of differentiated cells in each type II NB lineage. Mutants in mitochondrial fission protein Drp1 led to mitochondrial fusion but did not cause any differentiation defects. Decreased Notch signaling by the canonical pathway led to mitochondrial fragmentation and a decrease in differentiated cells in each type II NB lineage. Expression of Drp1 mutants in type II NB lineages depleted of Opa1 and Marf suppressed their proliferation and differentiation defects. Expression of Drp1 mutant in type II NB lineages depleted of Notch also led to a rescue of differentiated progeny in each lineage. Our results implicate crosstalk between Notch signaling, mitochondrial activity and fusion as important steps for proliferation and differentiation in the type II NB lineage.

Introduction

Mitochondria are sparse and fragmented in stem cells and are an elaborate network in differentiated cells [13]. Stem cells largely depend upon glycolysis as an energy source, whereas differentiated cells produce a large amount of ATP by electron transport chain (ETC) activity [1,4,5]. Fused mitochondrial morphology is associated with high membrane potential, increased ETC activity and high ATP production, while low membrane potential, reduced ETC activity and low ATP production is seen in fragmented mitochondria [1]. Mitochondrial architecture is regulated by a balance of fusion and fission events [6]. Proteins belonging to the family of large GTPases are involved in mitochondrial fusion and fission. Optic atrophy 1 (Opa1, or Opa1-like in Drosophila) and Mitofusin or Mitochondrial assembly regulatory factor (Marf in Drosophila or Mitofusin, Mfn in mammals) facilitate inner and outer mitochondrial membrane fusion respectively while Dynamin related protein 1 (Drp1) is required for mitochondrial fragmentation [710]. A balance of levels and activity of these proteins regulates mitochondrial shape in the cell [6]. Further, Opa1 plays a significant role in regulating cristae organization in addition to inner membrane fusion [11]. Opa1 oligomerization and inner membrane cristae organization is important for ETC activity. The presence of elaborate cristae leads to organization of ETC complexes as super complexes and enhances their activity [12]. Hyperfusion of mitochondria protects them from degradation in autophagy and also loss of ETC activity [1316].

Recent studies show that alteration of mitochondrial dynamics affects signaling pathways such as the Notch signaling pathway during stem cell differentiation. The Notch receptor is a transmembrane protein activated by ligands such as Delta. The Delta-Notch interaction is followed by cleavage of the Notch intracellular domain (NICD) in the signal receiving cell. NICD enters the nucleus and regulates gene expression along with Suppressor of hairless (Su(H)) by the canonical pathway thereby providing a signal for proliferation or differentiation [17]. Fragmented mitochondrial morphology maintained by Drp1 in ovarian follicle cells in Drosophila is crucial for activating Notch signaling [18,19]. Similarly, loss of Opa1 and Mfn leading to mitochondrial fragmentation in mouse embryonic stem cells causes hyperactivation of Notch and reduces differentiation of ESCs into functional cardiomyocytes due to loss of calcium buffering [20]. On the other hand, activation of Notch signaling by depletion of mitochondrial fusion and increasing reactive oxygen species (ROS) enhances differentiation in mammalian neural stem cells [21]. Thus mitochondrial fragmentation along with elevated calcium and reactive oxygen species increase has been found to be involved in Notch signaling in these contexts. It is of interest to understand whether Notch signaling induces appropriate mitochondrial morphology in differentiation.

The Drosophila neural stem cell or neuroblast (NB) differentiation model has been used effectively to identify regulators of steps of differentiation such as stem cell renewal, asymmetric cell division, polarity formation and lineage development. NBs rely on glycolysis and ETC activity for their energy production during differentiation and tumorigenesis [2224]. Mitochondrial fusion has recently been found to be essential for tumorigenesis [24]. It remains to be studied whether mitochondrial morphology is also regulated to provide appropriate mitochondrial activity for differentiation in NBs. The type I NB lineage in the larval brain consists of 90 NBs marked by the expression of the transcription factors Deadpan (Dpn) and Asense (Ase). These NBs divide asymmetrically to give rise to a ganglion mother cells (GMCs) marked by the expression of Prospero (Pros) in the nucleus [25,26]. NBs of the type II lineage express Dpn and are 8 in number per optic lobe [27]. Like the mammalian neural stem cell differentiation type II NBs undergo multiple steps of differentiation by forming transit amplifying cells called intermediate neural precursor cells (INPs). Newly formed INPs are smaller in size as compared to type II NBs and do not express Ase and Dpn. Some immature INPs express Ase. Immature INPs undergo a defined series of transcriptional changes to form mature INPs. Mature INPs express Dpn and Ase and proliferate to form GMCs that express nuclear Pros and Ase. GMCs in both the type I and type II lineages finally differentiate into neurons or glia (Fig 1A). Young neurons are present at the base of the lineage and express increased nuclear Pros. Elav is expressed in all neurons [28]. Notch signaling regulates number and differentiation in the type II NB lineage [29,30].

Fig 1. Opa1 and Marf depletion leads to fragmented mitochondria and overexpression of Drp1SD leads to clustered mitochondria in type II NBs.

Fig 1

A: Schematic of larval CNS (left) containing the central brain (CB) lobes and ventral nerve cord (VNC) and type I (blue) and type II NB (purple) distribution and lineages of type I (left) and type II NB (right). The type I NB lineage has nuclear Dpn (red) and Ase (green) and cytoplasmic Pros (light blue) expressing NBs, nuclear Ase (green) and Pros (light blue) expressing GMCs and high levels of nuclear Pros (dark blue) expressing neurons. The type II NB lineage has Dpn positive NBs (red nuclei), Dpn negative, Ase negative and Pros negative immature INPs (black and white), only Ase expressing immature INPs, nuclear Dpn (red) and cytoplasmic Pros (light blue) expressing mature INPs, nuclear Ase and Pros expressing GMCs (green nuclei) and high levels of nuclear Pros (dark blue) expressing young neurons. B-D: Mitochondrial morphology and distribution in type II NBs expressing pnt-Gal4, mCD8-GFP (white dotted line, magnified area shown in the panel on the right) stained with ATPβ (red) antibody using confocal imaging and STED super resolution microscopy is shown in representative single optical plane images with zoomed inset in the right panel (B). Single plane confocal images from mature INPs from each image are marked with Dpn and stained with mito-GFP (red). mCherry RNAi (32 type II NBs, 8 brains: 100% intermediate morphology; 40 mature INPs, 5 brains, 8 lineages, 75% intermediate, opa1 RNAi (46 type II NBs, 8 brains: 100% fragmented; 47 mature INPs, 3 brains, 9 lineages, 78% fragmented), marf RNAi (45 type II NBs, 8 brains: 100% fragmented; 21 mature INPs, 3 brains, 4 lineages, 61% fragmented), Drp1SD (80 type II NBs, 10 brains: 85% clustered; 34 mature INPs, 3 brains, 6 lineages, 79% clustered). Graph shows the distribution of mitochondria into fragmented, intermediate and clustered in the form of a stacked histogram (C). The percentage documented on each bar in the histogram is for the group that is seen at the maximum extent. Average mitochondrial area quantification from type II NBs (D) in mCherry RNAi (6 type II NBs, 3 brains), opa1 RNAi (6,3), marf RNAi (19,3), Drp1SD(6,3). Graph shows mean ± sd. Statistical analysis is done using an unpaired t-test. *** p<0.001. Scale bar- 5μm for the type II NB in B, 2.7μm for the mature INP in B.

In this study, we have assessed the role of mitochondrial morphology proteins Opa1, Marf and Drp1 in regulating type II NB differentiation. RNAi mediated knockdown of mitochondrial fusion proteins Opa1 and Marf led to mitochondrial fragmentation, loss of mitochondrial activity and defects in proliferation and differentiation in the type II NB lineage while NB number and polarity remained unaffected. Opa1 depletion led to decreased proliferation of the type II NBs and mature INPs and decrease in mature INPs, GMCs and neurons in the type II NB lineage. Marf depletion led to decreased proliferation of GMCs and loss of neurons in the type II NB lineage. On the other hand there was no defect in differentiation in NBs overexpressing a mutant form of mitochondrial fission protein Drp1. Inhibition of mitochondrial fragmentation in Opa1 and Marf depletion in combination with Drp1 mutant overexpression suppressed the differentiation defects suggesting that fused mitochondria are essential for differentiation in the type II NB lineage. Further, Notch depletion led to fragmented mitochondria and loss of differentiation. Increased Notch activity showed mitochondrial clustering. Mitochondrial fusion in the type II NB lineage deficient of Notch led to differentiation. Our results show that mitochondrial fusion interacts with Notch signaling to drive differentiation in the type II NB lineage.

Results

Depletion of mitochondrial morphology proteins Opa1, Marf and Drp1 leads to change in mitochondrial organization in type II NBs and mature INPs

We depleted Opa1, Marf and Drp1 to investigate the effect of perturbation of mitochondrial morphology on NB numbers and differentiation. We expressed multiple RNAi lines against Opa1, Marf and an RNAi line against Drp1 and a dominant negative Drp1 mutation with neuronal Gal4 drivers in different stages of NB differentiation to analyze their effect on lethality and behavior (S1 Fig). inscuteable-Gal4, worniu-Gal4, scabrous-Gal4 and prospero-Gal4 were used to deplete Opa1, Marf and Drp1 using RNAi expression and Drp1 using overexpression of a dominant negative mutant in all NBs. Opa1, Marf and Drp1 depletion by multiple RNAi lines and a dominant negative mutant showed survival of animals until the pupal stage with inscuteable-Gal4 and worniu-Gal4 and were lethal or showed behavioral defects as adults. The RNAi lines for Opa1 and Marf that gave a stronger defect with inscuteable-Gal4 and worniu-Gal4 and overexpression of the dominant negative mutant of Drp1, (Drp1SD) [31] were used to deplete these proteins in the type II NB lineage using pointedP1-Gal4, mCD8-GFP (pnt-Gal4, mCD8-GFP) for further experiments (Figs 1A and S1). opa1 RNAi, marf RNAi and Drp1SD expression in the type II NB lineage gave normal adults at 25°C. opa1 RNAi and marf RNAi expression in type II NB lineage when performed at a higher temperature of 29°C with pnt-Gal4 gave sluggish adults.

To characterize mitochondrial morphology in type II NBs, we performed super-resolution Stimulated Emission Depletion microscopy (STED). Mitochondria were stained with an antibody against ATPβ subunit of complex V in the third instar larval brain. STED microscopy allowed better separation of mitochondria in these small cells as compared to confocal microscopy (Figs 1B and S2A). We observed mitochondria in a bead-like organization, often present as spheres evenly distributed all around the nucleus in control type II NBs (Figs 1B and S2A). The mitochondrial morphology was similar to previous observations in type I NBs [32]. We used pnt-Gal4, mCD8-GFP to identify the type II NBs using mCD8-GFP and deplete Opa1 and Marf and express the Drp1SD mutant. Pnt expresses in type II NBs, immature INPs and mature INPs [33]. Partial loss of pnt leads to a decrease in mature INPs and GMCs in the type II NB lineage. Pnt-Gal4, mCD8-GFP shows GFP expression in type II NBs, brighter GFP in cells closer towards the type II NB and lighter GFP in cells towards the base of the lineage. RNAi against mitochondrial fusion proteins Opa1 and Marf has been previously shown to deplete the corresponding mRNA and lead to mitochondrial fragmentation in electron microscopy studies [3437]. We classified mitochondrial morphology into fragmented, intermediate and clustered in different genotypes in type II NBs and mature INPs by analyzing their distribution in different optical planes (Fig 1B and 1C). We observed an increase in numbers of type II NBs containing mitochondria in a fragmented form often organized as small spheres on depletion of Opa1 and Marf using two different RNAi lines as compared to an intermediate mitochondrial morphology in mCherry RNAi controls, confirming the requirement of these proteins for mitochondrial fusion (Figs 1B, 1C, and S2A). NBs depleted of Opa1 and Marf showed a significant decrease in mitochondrial area as compared to controls (Figs 1D and S2B). The extent of decrease in mitochondrial area was similar upon depletion of either Opa1 or Marf. Mature INPs (Dpn+ cells in the lineage) expressing Opa1 and Marf RNAi also showed increased numbers of cells containing fragmented mitochondria as compared to an intermediate state in controls (Fig 1B and 1C).

Overexpression of mitochondrial fission mutant Drp1SD resulted in clustering of mitochondria on one side of the NB suggesting that mitochondria were fused (Fig 1B). We observed a similar clustering of mitochondria in mitotic clones of type II NBs depleted of Drp1 using the null allele of drp1, drp1KG [38] (S2C Fig). Mitochondrial clustering on Drp1 depletion has been seen earlier in mammalian cells [39,40] and also in Drosophila spermatocytes, neurons, follicle cells and embryos [18,19,31,41,42]. Mitochondrial clusters have inter connected mitochondrial tubes in electron microscopy studies in mammalian cells [40]. Drp1 depletion led to an increase in numbers of type II NBs showing clustered mitochondria and a significant increase in mitochondrial area as compared to control NBs (Fig 1C and 1D). Mature INPs expressing Drp1SD also showed an increased number of cells with clustered mitochondria (Fig 1B and 1C). We confirmed the effect of mitochondrial morphology protein depletion on mitochondrial morphology in muscle cells using mhc-Gal4, mito-GFP. In line with the previous studies [34,43,44] and NB data, we found that mitochondria were relatively smaller upon depletion of Opa1 and Marf in muscle cells. Expression of Drp1SD resulted in relatively large mitochondria compared to control (S2D Fig). Whereas our analysis of mitochondrial distribution could capture changes in mitochondrial morphology at the qualitative level, it could not ascertain changes in mitochondrial size and density of mitochondria in the type II NBs and mature INPs. In summary, depletion of Opa1 and Marf led to mitochondrial fragmentation and depletion of Drp1 led to mitochondrial clustering consistent with mitochondrial fusion in the type II NBs.

Loss of mitochondrial fusion by depletion of Opa1 and Marf leads to decrease in differentiated cells in the type II NB lineage

We assessed the effect of knockdown of mitochondrial morphology proteins on NB number and differentiation. Depletion of mitochondrial morphology proteins in type II NBs with pnt-Gal4, mCD8-GFP did not change their numbers (S3A and S3B Fig). Further we assessed different cell types present in each type II NB lineage based on their specific molecular profile (Figs 1A, 2A and 2B). The numbers of immature INPs (Ase- Pros- cells) were similar in Opa1, Marf and Drp1 depleted type II NB lineages (Fig 2C). Interestingly, mature INPs (Dpn+ Ase+ cells) were significantly decreased in opa1 RNAi as compared to mCherry RNAi controls (Fig 2A and 2D). Mature INPs give rise to GMCs which further divide to form a pair of neurons. Young neurons contain relatively increased levels of Pros and are located at the base of the lineage. Consistent with the decrease in mature INPs, we observed that GMCs (Dpn- Ase+ cells, yellow arrows) (Fig 2A and 2E) and young neurons (Pros high cells) (Fig 2B and 2F) were also reduced in Opa1 depletion. We further confirmed this result of loss of mature INPs and neurons in an independent RNAi line against Opa1 (S3A, S3C, S3D and S3E Fig). Bonnay et al [24] report an increase in mature INPs with a VDRC RNAi line used for depletion of Opa1 in a recent study. We also checked this line for differentiation defects and found that mature INPs and GMCs were decreased on Opa1 depletion (S3F and S3G Fig). We found a consistent decline in mature INPs and GMCs across multiple RNAi lines for Opa1 depletion.

Fig 2. Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins.

Fig 2

A-F: Representative images of the type II NB lineage showing that Dpn positive mature INPs (grey) and Dpn negative, Ase positive GMCs (yellow arrows) are reduced in opa1 RNAi (A). Quantification of Dpn positive mature INPs per type II NB lineage (D) in mCherry RNAi (n = 11 type II NB lineages, 4 brains), opa1 RNAi (21,6), marf RNAi (15,8), Drp1SD (28,10). Quantification of GMCs per type II NB lineage (E) in mCherry RNAi (n = 19 type II NB lineages, 6 brains), opa1 RNAi (14,5), marf RNAi (17,6), Drp1SD (14,5) Scale bar- 10μm. Quantification of Ase negative and Pros negative (Ase- Pros-) (C) immature INPs per type II lineage. mCherry RNAi (24 type II NB lineages,5 brains), opa1 RNAi (20,7), marf RNAi (23,8), Drp1SD (19,8). Representative images of type II NB lineages showing high levels of Pros expressing young neurons are reduced in opa1 RNAi and marf RNAi (B). Quantification of number of young neurons expressing high levels of Pros (yellow arrows point to nuclear Pros) per type II NB lineage (F) of mCherry RNAi (13 type II NB lineages,4 brains), opa1 RNAi (18,5), marf RNAi (19,5), Drp1SD (26,9). Scale bar- 10μm. G: Schematic depicting the effect of depletions of Opa1, Marf and Drp1 on different cell types in the type II NB lineage. C-F: Graphs show mean ± sd. Statistical analysis is done using an unpaired t-test. ns = non-significant, ***- p<0.001.

Marf depletion did not alter mature INPs in each type II NB lineage (Figs 2A, 2D, S3A, S3D, S3F and S3G) but led to an increase in GMCs as compared to controls (Fig 2A and 2E). This was also seen in another VDRC line recently used for Marf depletion (S3F and S3G Fig). Conversely, the numbers of young neurons were decreased in marf RNAi expressing type II NBs (Figs 2B, 2F, S3C and S3E). The lack of change of mature INPs and increase in GMCs along with a decrease in young neurons in each lineage on Marf depletion implied that GMCs were not able to give rise to neurons.

Depletion of Drp1 causes loss of follicle cell differentiation in Drosophila follicle cells [18,19]. However, we did not find any change in numbers of type II NBs and mature INPs, GMCs and young neurons in each Drp1SD expressing type II NB lineage as compared to controls (Fig 2A, 2B, 2D, 2E and 2F). These data suggest that Drp1 activity is not required for type II NB differentiation while Opa1 and Marf depletions impairs differentiation in the type II NB lineage.

We also depleted mitochondrial morphology proteins using worniu-Gal4 to estimate the total numbers of type I and II NBs per brain lobe. The total NB number did not change upon depletion of Opa1, Marf and Drp1 (S4A and S4B Fig). Further we analyzed the apico-basal polarity in NBs by probing polarity markers Bazooka and Numb. Apico-basal distribution of polarity proteins Bazooka and Numb in metaphase is essential for fate determination in the lineage [26]. We found that the NBs did not show a defect in asymmetric localization of Bazooka and Numb on depletion of Opa1, Marf or Drp1 (S4C Fig). However, the numbers of differentiated cells (Pros+ cells) in each brain lobe were decreased in opa1 RNAi but not marf RNAi (S4D and S4E Fig).

In summary, depletion of Opa1 led to a decrease in numbers of differentiated progeny in the type II NB lineage to a greater extent compared to Marf, despite the comparable disruption of mitochondrial morphology. Depletion of mitochondrial fission protein Drp1 did not show any defects in numbers of differentiated progeny in the type II NB lineage (Fig 2G). The phenotype of increased mitochondrial fragmentation and delay in NB division leading to loss of differentiation has been previously noted on depletion of ETC components [23]. Apart from mitochondrial fusion, Opa1 is also involved in the maintenance of cristae architecture [11,4547]. It is, therefore, possible that a specific defect in mitochondrial inner membrane organization caused by Opa1 depletion in addition to the loss of fusion leads to a decrease in mature INPs and GMCs in the type II NB lineage.

Drp1SD overexpression along with Opa1 or Marf depletion shows clustered mitochondria and suppresses the defects in differentiation in the type II NB lineage

Mitochondrial fragmentation in Opa1 and Marf depleted cells requires the activity of mitochondrial fission protein Drp1 [31,34,48,49]. To alleviate the mitochondrial fragmentation defect seen in Opa1 and Marf knockdown, we generated combinations of Drp1SD;mCherry RNAi, Drp1SD;opa1 RNAi and Drp1SD;marf RNAi with pnt-Gal4 and analyzed mitochondrial morphology in NBs and mature INPs. Unlike opa1 RNAi and marf RNAi (Fig 1B), the Drp1SD;opa1 RNAi and Drp1SD;marf RNAi combinations showed increased numbers of type II NBs and mature INPs containing clustered mitochondria and these cells also showed mitochondria with an increased area as compared to controls (Fig 3A, 3B and 3C). The mitochondrial cluster in the type II NB was more resolved as compared to controls and Drp1SD;mCherry RNAi, with a few punctate mitochondria appearing at the edges of the cluster and a small but significant decrease in mitochondrial area in Drp1SD;opa1 RNAi and Drp1SD;marf RNAi combinations (Fig 3A and 3C).

Fig 3. Drp1SD overexpression in opa1 RNAi and marf RNAi expressing type II NB lineages suppresses the differentiation defect.

Fig 3

A-C: Representative images with zoomed inset in the right panel of type II NBs (white dotted line) containing pnt-Gal4, mCD8-GFP (green) stained for mitochondrial morphology with ATPβ (red) and imaged using STED. Mitochondria in mature INPs (Dpn+ cells, grey) are labeled using mito-GFP (red) (A). pnt-Gal4, mCD8-GFP with Drp1SD;opa1 RNAi (96 type II NBs,12 brains: 5% clustered; 41 mature INPs, 3 brains, 8 lineages 71% clustered), Drp1SD;marf RNAi (96 type II NBs,12: 86% clustered; 60 mature INPs, 4 brains, 11 lineages 72% clustered). Quantification of average mitochondrial area (B) in type II NB of mCherry RNAi (8 Type II NBs, 3 brains), Drp1SD (5, 3), Drp1SD;mCherry RNAi (9,4),Drp1SD;opa1 RNAi (16,4), Drp1SD;marf RNAi (12,4). Graph shows the distribution of mitochondria into fragmented, intermediate and clustered in the form of a stacked histogram (C). The percentage documented on each bar in the histogram is for the group that is seen at the maximum extent. The values for Drp1SD are repeated from Fig 1 for comparison. Scale bar- 5μm for the type II NB, 2.7μm for the mature INPs. D,E,G: Type II NB lineages (yellow dotted line) showing expression of mCD8-GFP (green) Ase (red) and Dpn (grey) (D). Quantification of Dpn positive mature INPs (E) in mCherry RNAi (13 NB lineages,4 brains), Drp1SD;mCherry RNAi (27,10), opa1 RNAi (20,8), Drp1SD;opa1 RNAi (8,6), marf RNAi (13,8), Drp1SD;marf RNAi (35,8). Quantification of Ase positive and Dpn negative GMCs (G, yellow arrows) in mCherry RNAi (19 type II NB lineages,6 brains), Drp1SD;mCherry RNAi (18,5), opa1 RNAi (14,5), Drp1SD;opa1 RNAi (13,5), marf RNAi (17,6), Drp1SD;marf RNAi (17,6). Scale bar- 10μm. F,H: Type II NBs lineages (white dotted line) showing expression of mCD8-GFP (green) and Pros (red, yellow arrows point to nuclear Pros) (F). Quantification of high levels of Pros expressing young neurons (H) in mCherry RNAi (13 NB lineages,4 brains), Drp1SD; mCherry RNAi (13,5), opa1 RNAi (20,8), Drp1SD;opa1 RNAi (25,8), marf RNAi (14,8), Drp1SD;marf RNAi (33,8). Scale bar- 10μm. B,E,G,H: Graphs show mean ± sd. Comparative analysis was done by using unpaired t-test. ns- non significant,*- p<0.1, **- p<0.01, ***- p<0.001.

We next analyzed the numbers of different cells in the lineage in the Drp1SD;opa1 RNAi and Drp1SD;marf RNAi combinations (Fig 3D, 3E and 3H). The numbers of mature INPs increased in Drp1SD;opa1 RNAi as compared to opa1 RNAi and were not significantly different from controls and Drp1SD;mCherry RNAi (Fig 3D and 3E). A slight but non-significant increase in the numbers of mature INP in marf RNAi was also rescued by co-expression of Drp1SD (Fig 3D and 3E). A similar rescue in GMC (Dpn- Ase+ cells, yellow arrows) numbers were also observed upon co-expression of Drp1SD with both opa1 RNAi and marf RNAi (Fig 3D and 3G). A partial rescue was observed in young neuron (Pros High cells) numbers in Opa1 and Marf depleted type II NB lineages upon forced mitochondrial fusion/clustering (Fig 3F and 3H). Further, we confirmed that rescue in numbers of differentiated cells upon Drp1SD expression was not due to dilution of the Gal4 by expressing UAS-RFP in Opa1 and Marf depletion backgrounds. Expression of UAS-RFP did not change the altered numbers of Dpn+, Ase+, and Pros high+ cells in type II NB lineages caused by Opa1 and Marf depletions (S5A, S5B, S5C, S5D, S5E and S5F Fig) confirming that rescue in type II NB differentiation was indeed due to reduced activity of Drp1. In summary, the differentiation defect observed on Opa1 and Marf depletion was partially suppressed on mitochondrial fusion with Drp1SD.

Decrease in mitochondrial activity in Opa1 and Marf depleted type II NBs is suppressed by overexpression of Drp1SD

Changes in mitochondrial morphology can affect mitochondrial membrane potential and activity. Mitochondrial membrane potential (MMP) is a readout for mitochondrial quality and functionality [50]. We assessed the effect of mitochondrial dynamics proteins depletion on MMP by using the potentiometric dye, Tetra-methyl-rhodamine methyl ester (TMRM) in vivo in living larval brains by live imaging. We estimated the relative fluorescence obtained from uptake of TMRM in mCD8-GFP marked type II NBs as compared to neighboring unmarked controls. We found a significant decrease in TMRM fluorescence and therefore MMP on depletion of Opa1 and Marf whereas Drp1SD expression did not affect the MMP (Fig 4A and 4B). Co-depletion of Drp1 along with opa1 or marf RNAi suppressed the MMP defect suggesting that outer mitochondrial membrane fusion restores mitochondrial membrane potential (Fig 4A and 4B).

Fig 4. Drp1SD overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential.

Fig 4

A, B: Representative images showing decreased TMRM intensity in opa1 RNAi and marf RNAi expressing type II NBs. Percentage of type II NBs showing similar intensity profile to the representative images is shown on the image panel for each genotype. pnt-Gal4, mCD8-GFP (+/+, 17 type II NBs, 8 brains), Drp1SD (9,5), opa1 RNAi (16,5), Drp1SD;opa1 RNAi (11,4), marf RNAi (11,5), Drp1SD;marf RNAi (7,4). Scale bar- 10μm (A). Graph showing normalized TMRM intensities in +/+ (17 type II NBs, 8 brains), Drp1SD (9,5), opa1 RNAi (16,5), Drp1SD;opa1 RNAi 7,4), marf RNAi (11,5), Drp1SD;marf RNAi (6,4) (B). C, D: Representative confocal images of larval NBs (C) showing increased cytochrome C staining in opa1 RNAi using worniu-Gal4. Analysis of cytochrome C intensity normalized with control (D). +/+ (19 NBs, 8 brains), opa1 RNAi (22 NBs, 7 brains), marf RNAi (23 NBs, 7 brains). B,D: Graphs show mean ± sd. Comparative analysis was done by using unpaired t-test. ns- non significant, **- p<0.01, ***- p<0.001.

Decrease in MMP observed in opa1 and marf RNAi may result in a drop in ATP levels in the cell that could trigger a stress response. We have previously found that change in ETC activity but not mitochondrial fusion obtained by Drp1 depletion causes ATP stress in Drosophila embryos [31,51]. Depletion of ATP causes an increase in AMP levels which further triggers phosphorylation of AMP activated protein kinase (pAMPK). pAMPK levels elevate in energy deprived conditions and act as an energy sensor inside the cell [52]. To check whether ATP stress was seen in mitochondrial fusion protein depleted NBs, we stained brains with antibodies against pAMPK. NB differentiation relies at least in part on glycolytic metabolism for ATP and loss of ATP in ETC mutants is seen when depleted of both glycolysis and ETC activity [22,23]. Therefore as a positive control for reduction in glycolysis and induction of pAMPK we added 2-deoxy-glucose (2-DG), a non-hydrolysable analogue of glucose to larval brains after dissection and observed a significant increase in pAMPK levels throughout the brain. However, we did not observe a change in pAMPK levels in Opa1 and Marf depleted type II NBs as compared to neighboring NBs indicating that ATP stress similar to 2-DG treatment was not seen in these depletions (S6A and S6B Fig). This shows that activation of pAMPK in NBs depleted of Opa1 and Marf was lower as compared to that seen when glycolysis was inhibited with 2-DG.

Another consequence of change in mitochondrial morphology is alteration in the levels of reactive oxygen species (ROS) [53,54]. We estimated ROS levels using Dihydroxy ethidium (DHE) fluorescence in NBs as compared to neighboring cells. Consistent with previous studies [36,55], we observed an increased DHE fluorescence indicating an increased ROS on Opa1 knockdown and Drp1SD expression (S7A and S7B Fig). Marf depletion however did not change the DHE fluorescence significantly (S6A and S6B Fig). Since ROS was found to increased in both Opa1 depletion and Drp1SD NBs, and there was no effect on differentiation on Drp1SD overexpression (Fig 2), we conclude that ROS is unlikely to play a significant role in differentiation in type II NBs. We further checked if a general increase in ROS can affect development. We found that in type I and II NBs overexpressing a mutant of human Superoxide dismutase (hSOD) [31,56], ROS was increased significantly (S7A and S7B Fig). However, hSOD expression in all NBs did not affect viability of flies and adults emerged similar to controls leading us to conclude that it did not impact differentiation and functionality of neurons.

Even though both Opa1 and Marf depletion led to an equivalent fragmentation and loss of MMP of mitochondria in NBs, Opa1 depletion showed a specific decrease in mature INPs as compared to Marf knockdown. Opa1 oligomerization leads to stabilization of cristae and localization of cytochrome c in cristae. Increase in cytochrome c occurs when Opa1 oligomerization is decreased and this correlates with loose cristae organization [45]. We visualized the distribution of cytochrome c in Opa1 and Marf depleted NBs. Increase in cytochrome c was seen in opa1 RNAi as compared to marf RNAi and controls (Fig 4C and 4D). This suggests that loosening of cristae architecture potentially causes specific spread of the cytochrome c signal on Opa1 depletion. Altogether, loss of MMP in type II NBs and increased cytochrome c in NBs deficient of Opa1 is suggestive of disruption of inner mitochondrial membrane architecture and activity in addition to fusion leading to loss of differentiation.

Opa1 and Marf depleted type II NB lineages show proliferation defects

The decreased lineage size observed in Opa1 and Marf depleted type II NBs may result from apoptosis or lowered proliferation rates of each NB, thereby reducing the numbers of INPs and GMCs in each lineage. Increased cytochrome C and ROS in Opa1 depletion suggests that type II NB differentiation could be decreased by apoptosis in the lineage [54,5759]. For probing apoptosis, we assessed the levels of cleaved caspase 3 in opa1 and marf RNAi. Cleaved caspase 3 fluorescence was not elevated in Opa1 and Marf depleted lineages and was similar to controls (S8A Fig). Selectively marking apoptotic nuclei with the Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay did not show any significant difference between opa1 RNAi and control. We validated this assay by using UAS-hid expression as a positive control for apoptosis induction (S8B and S8C Fig). Therefore, cell death is not responsible for the differentiation defect in Opa1 and Marf depleted type II NBs.

Change in mitochondrial morphology impacts the rate of proliferation and differentiation in mammalian stem cells by regulating levels of cyclins [60,61]. Type II NBs divide asymmetrically to produce INPs, mature INPs divide asymmetrically to produce GMCs and GMCs divide to produce neurons and glia in the type II NB lineage. We analyzed the numbers of cells in type II NBs and their lineage cells in the mitotic phase by labeling them with phospho-histone 3 (pH3) antibody. We found that the numbers of type II NBs in mitosis were significantly reduced on Opa1 depletion and this defect was rescued in the Drp1SD;opa1 RNAi combination (Fig 5C). The total numbers of pH3 positive cells in the lineage were decreased (Figs 5A and S9C). The total number of cells in G1-S phase as marked by EdU in the lineage were also decreased (Fig 5B and 5F). This decrease in the numbers of cells in the mitotic and G1-S phase was rescued partially on additional expression of the Drp1SD mutant (Figs 5A, 5B, 5F and S9C). Drp1SD expression alone did not perturb the proliferation of the type II NB or the lineage cells. We also found that there was a decrease in the numbers of mitotic NBs when opa1 RNAi was expressed with worniu Gal4 (S9A and S9B Fig). We further assessed the numbers of mature INPs labeled with Dpn in mitosis in each type II NB lineage with pH3. We found that the mitotic Dpn positive mature INPs were depleted in opa1 RNAi and this defect was suppressed in Drp1SD;opa1 RNAi (Fig 5D). These data together show that decreased division rate of the type II NB gives rise to less mature INPs. The mature INPs produced in turn also divide less thereby impacting GMC and neuron numbers in the lineage.

Fig 5. Proliferation defects in Opa1 depleted type II NB lineages are suppressed by overexpression of Drp1SD.

Fig 5

A,C-E: Representative confocal images of type II NB lineages show reduced pH3 positive mature INPs (A) in opa1 RNAi while increase in marf RNAi expressed with pnt-Gal4, mCD8-GFP in the type II NB lineage. Analysis of mitotic type II NBs per brain lobe (C) in mCherry RNAi (10 brain lobes), Drp1SD (6), opa1 (8), Drp1SD;opa1 RNAi (10), marf RNAi (12), Drp1SD;marf RNAi (10). Analysis of percentage of dividing mature INPs in type II NB lineages (D, yellow arrows are Dpn+pH3+) in mCherry RNAi (33 Type II NB lineages,7 brains), Drp1SD;mCherry RNAi (24,6), opa1 (33,6, Drp1SD;opa1 RNAi (26,8), marf RNAi (33,8), Drp1SD;marf RNAi (15,5). Quantification of percent dividing GMCs (E) in mCherry RNAi (16 typeII NB lineages, 4 Brains), marf RNAi (9,2), Drp1SD;marf RNAi (14,5), Scale bar- 10μm. Non-parametric unpaired t-test with Welch’s correction was used for statistical analysis. ns- non-significant, *- p<0.1, **- p<0.01, ***- p<0.001. B,F:Representative confocal images of type II NB lineages (mCD8-GFP, green) (yellow dotted line) show decreased number of EdU (red) positive cells per lineage (B) in opa1 RNAi. Quantification of EdU positive cells in type II NB lineages (F) in pnt-Gal4, mCD8-GFP +/+ (35 Type II NB lineages, 6 Brains), Drp1SD (21,7), opa1 RNAi (26,6), Drp1SD;opa1 RNAi (23,7), marf RNAi (29,7), Drp1SD;marf RNAi (14,5). Statistical analysis was done by using unpaired t-test.ns- non-significant, **- p<0.01, ***- p<0.001.

Depletion of Marf did not impact the division rate of the type II NB when expressed with pnt or worniu Gal4 (Figs 5C, S9A, and S9B). The division rate of Drp1SD;marf RNAi combinations was slightly increased as compared to marf RNAi and controls. There was a significant increase in pH3 and EdU positive cells in each type II NB lineage and this was rescued on additional expression of the Drp1 mutant (Figs 5A, 5B, 5F and S9C). There was a significant increase in mitotic mature INPs in the lineage (Fig 5D). This phenotype was not significantly suppressed by addition of Drp1SD even though the variation in numbers of mitotic cells decreased as compared to marf RNAi alone. The mitotic GMCs however were significantly decreased and this decrease was suppressed by addition of Drp1SD (Figs 5E and S9D). This increase in mitosis in mature INPs and decrease in the mitotic rate of the GMCs causes an increase in GMC numbers and decrease in numbers of neurons.

These data altogether suggest that decrease in the division of type II NBs and mature INPs in opa1 RNAi and GMCs in marf RNAi is responsible for the loss of differentiation in the type II NB lineage.

Notch signaling drives fused mitochondrial morphology and Opa1 depletion leads to decreased Notch signaling in the type II NB lineage

Notch signaling regulates numbers of NBs and their differentiation in the type II lineage in the Drosophila third instar larval brain [29,30,62]. Changes in the cell cycle could impact Notch signaling [63]. Notch signaling is activated in type II NBs and suppressed in immature INPs. Notch signaling is again activated in the mature INPs in the lineage. Loss of Notch signaling leads to decreased type II NBs and transformation of the type II NB to the type I NB with absence of Dpn positive mature INPs. Increased Notch signaling gives rise to increased NBs due to dedifferentiation of immature INPs [30,64]. NBs formed on overexpression of NotchFL express Dpn but do not express Ase (S10A and S10B Fig). Also depletion of Opa1 and Marf led to a significant decrease in numbers of NBs in the Notch overexpression background (S10C and S10D Fig).

Since Notch signaling regulates differentiation within each type II NB lineage (Fig 6A and 6B) and loss of mitochondrial fusion proteins led to loss of differentiation in the type II NB lineage, we assessed if Notch signaling regulates mitochondrial morphology in type II NBs. Elongated and fused mitochondrial morphology has been observed in the type II NBs depleted the Notch inhibitor, Numb [24]. We also observed a change in the mitochondrial morphology on increasing Notch activation in type II NBs which were positive for Dpn (Fig 6C). Overexpression of the Notch full length, NotchFL and the Notch intracellular domain, Nintra in type II NBs led to a significant increase in cells containing clustered mitochondria on one side of the nucleus (Fig 6C and 6D). Overexpression of NotchFL and Nintra led to an increase in the area of mitochondria as compared to control NBs (Fig 6C and 6E). Notch downregulation by expression of notch RNAi led to an increase in numbers of cells containing fragmented mitochondria and a decrease in average size of punctae (Fig 6C and 6E). Likewise, depletion of Su(H) in type II NBs also resulted in increase in numbers of cells containing fragmented mitochondria and decreased area of mitochondria (Fig 6C and E). These data show that Notch activation via the canonical pathway through Su(H) leads to mitochondrial clustering and fusion whereas Notch depletion results in fragmented mitochondria. We also assessed mitochondrial distribution on Notch overexpression and downregulation in the mature INPs. We found that mitochondria were clustered on Notch overexpression in greater numbers of mature INPs and they were dispersed on Notch and Su(H) depletion in greater numbers of mature INPs as compared to controls (S10E and S10F Fig). Expression of Notch mutants in muscle cells also gave a similar result of larger mitochondria in Notch overexpression and smaller mitochondria on depletion of Notch in Notch RNAi and Su(H) RNAi (S10G Fig).

Fig 6. Analysis of mitochondrial morphology in Notch mutants and Notch signaling in Opa1 depleted type II NB lineages.

Fig 6

A:B: Representative confocal images of type II NB lineages (A) showing reduced numbers of mature INPs in notch RNAi. Quantification of mature INPs (B) in Control (16 type II NB lineages, 4 brains), NotchFL (15,5), notch RNAi (5,3). C-E: Type II NBs (mCD8-GFP, green, yellow dotted line) showing Notch signaling mediated regulation of mitochondrial morphology (red) by ATPβ antibody using STED microscopy (C). +/+ (100% tubular, 75 NBs, 22 Brains), NotchFL (68% clustered, 103,16), Nintra (76% clustered, 58,6), notch RNAi (50% fragmented, 30,14), su(H) RNAi (80% fragmented, 23,12). Graph shows the distribution of mitochondria into fragmented, intermediate and clustered in the form of a stacked histogram (D). The percentage documented on each bar in the histogram is for the group that is seen at the maximum extent. Average mitochondrial area quantification (E) in +/+ (9 Type II NBs,3 brains), NotchFL (22,5), Nintra (15,4), notch RNAi (16,4), su(h) RNAi (17,4). Scale bar- 5μm. F-H: Type II NBs (mCD8-GFP, green, yellow dotted line) stained for NICD (F) and observed for distribution in +/+, Drp1SD, opa1 RNAi, Drp1SD;opa1 RNAi, marf RNAi, Drp1SD;marf RNAi. Quantification of NICD in type II NBs (G) in +/+ (19,10), opa1 RNAi (20,12), marf RNAi (15,12), Drp1SD (22,5), Drp1SD;opa1 RNAi (28,6), Drp1SD;marf RNAi (11,5). Quantification of membrane NICD intensities in lineage (H, yellow arrows) in +/+ (6 lineages,3 brains), Drp1SD (10,4), opa1 RNAi (9,3), marf RNAi (9,3), Drp1SD;opa1 RNAi (9,4), Drp1SD;marf RNAi (8,4). Scale bar- 10μm. I: Representative confocal images of type II NB lineages showing expression of E(spl)mγ-GFP (green) in type II NB (large Dpn+ dotted large circles) and mature INPs (small Dpn+ dotted small circles). B, D, F & G: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant, *- p<0.1, **- p<0.01, ***- p<0.001.

Since Opa1 depletion led to decrease in the number of mature INPs, we tested the status of Notch receptor in the type II NBs. We found that the Notch receptor accumulated in the cytoplasm in Opa1 depleted type II NBs as visualized by the Notch intracellular domain antibody (Fig 6F, 6G and 6H). We also observed perturbed localization of Notch receptors in the differentiated cells in the lineage on Opa1 depletion (Fig 6F and 6H). This phenotype was suppressed in Drp1SD;opa1 RNAi (Fig 6F, 6G and 6H). We further assessed the activation of Notch signaling using the Notch reporter E(spl)mγ-GFP in the type II NB lineage. As expected, E(spl)mγ-GFP was found to be present in the type II NBs and mature INPs. We found that E(spl)mγ-GFP was present in type II NBs depleted of Opa1 (Fig 6I). However, there was a striking loss in E(spl)mγ-GFP expression in mature INPs (Fig 6I). The aberrant presence of Notch receptor in the cytoplasm in the type II NB did not visibly affect the activation of Notch in the NB, but Notch receptor localization and activation was abolished in the mature INPs.

Marf depletion did not show a defect in Notch receptor localization in the type II NBs and in the lineage (Fig 6F, 6G and 6H). Notch receptor distribution was also comparable to controls in Drp1SD (Fig 6F, 6G and 6H). Marf and Drp1 depletion did not show a change in E(spl)mγ-GFP expression in the type II NB and lineage cells (Fig 6I).

Taken together these observations suggest that Notch accumulates in the cytoplasm and Notch pathway activation is reduced in Opa1 depleted type II NB lineages. However, unlike notch RNAi, there was no loss of type II NBs on depletion of mitochondrial fusion. These data show that the depletion of Opa1 does not completely inhibit Notch activity like notch RNAi to cause loss of type II NB numbers; rather it leads to a defect in formation and function of mature INPs thereby causing a decrease in numbers of differentiated progenies in the type II NB lineage. Loss of Notch signaling on Opa1 depletion suggests that there is a feedback between Notch signaling and mitochondrial fusion in type II NB differentiation.

Mitochondrial fusion by overexpression of Drp1SD induces differentiation in Notch depleted type II NB lineages

Our data shows that mitochondrial fusion on Drp1SD overexpression did not have any differentiation defects and it also suppressed the differentiation defect in Opa1 depleted type II NB lineages. Recent studies show a role of mitochondrial fusion in proliferation of tumor NBs [24]. The transcription of Opa1 and Marf increases in brat RNAi and expression of Opa1 and Marf is important for proliferation of tumor NBs. We further tested whether mitochondrial fusion would drive differentiation in type II NB lineages depleted of Notch. We combined Drp1SD to generate fused mitochondria along with notch RNAi, expressed this combination in the type II NB lineage and stained the brains for Dpn and Ase to count the mature INPs and GMCs and Prospero to count the young neurons (Fig 7A, 7B, 7C, 7D, 7E and 7F). The numbers of type II NBs remained less than controls in the Drp1SD;notch RNAi combination and were similar to notch RNAi (Fig 7C). This observation further confirms that mitochondrial fusion does not affect Notch signaling in the type II NB. The loss of mature INPs (Dpn+) in notch RNAi expressing lineages was suppressed partially (Fig 7A and 7D). The loss of GMCs (Dpn- Ase+) in notch RNAi did not change in the notch RNAi and Drp1SD combination (Fig 7A and 7E). The numbers of young neurons labeled with bright Pros cells also did not change significantly on expression of Drp1SD in notch RNAi (Fig 7B and 7F). These results show that fused mitochondrial morphology can alleviate Notch signaling defects in type II NBs to drive the formation of mature INPs in the type II NB lineage. This suppression is partial and is not seen in the GMCs and neuron number in the lineage.

Fig 7. Drp1SD overexpression partially alleviates the differentiation defect seen in notch RNAi expressing type II NB lineages.

Fig 7

A, C-E: Type II lineages (pnt-Gal4, mCD8-GFP, green) showing Dpn positive INPs (grey) and Dpn negative Ase positive GMCs (yellow arrows) (A). Quantification of number of type II NBs (C) in +/+ (16 Brains), Drp1SD (13), notch RNAi (27), Drp1SD;notch RNAi (21). Quantification of Dpn positive mature INPs (D) in +/+ (23 Type II NB lineages,16 brains), Drp1SD (28,10), notch RNAi (50,9), Drp1SD;notch RNAi (25,5). Quantification of GMCs (E) in mCherry RNAi (19 Type II NB lineages, 6 Brains), Drp1SD (14,5), notch RNAi (9,6), Drp1SD;notch RNAi (8,4).Scale bar- 10μm. B,F: Type II lineages (pnt-Gal4, mCD8-GFP, green) showing high Pros expressing young neurons (B) (red, yellow arrows). Quantification of Dpn- Ase+ GMCs (F) in +/+ (29 NB lineages,18 brains), Drp1SD (26,8), notch RNAi (45,5), Drp1 SD;notch RNAi (9,5). Scale bar- 10μm. C-F: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant, *- p<0.1, **- p<0.01, ***- p<0.001.

Taken together, our results show that Notch signaling regulates fused mitochondrial morphology and mitochondrial fusion is important for differentiation in the type II NB lineage. This is also consistent with the requirement of mitochondrial fusion in NB tumors induced in brat and numb mutants, since depletion of mitochondrial fusion and not mitochondrial fission abrogates the tumor phenotype in brat and numb mutant NBs [24]. In summary, we find that mitochondrial fusion controlled by Opa1 and Marf regulates Notch signaling driven differentiation in the Drosophila type II NB lineage.

Discussion

Recent evidence shows that maintenance of mitochondrial architecture is critical for cell fate determination [6567]. Depletion of ETC components in Drosophila NBs leads to mitochondrial fragmentation, loss of differentiation and cancer progression [2224]. Here we show that mitochondrial fusion proteins, Opa1 and Marf affect proliferation and differentiation in the type II NB lineage. Opa1 and Marf gave equivalent fragmentation and loss of mitochondrial activity in the type II NB. Opa1 and Marf depletion changes the mitochondrial density. However, decreasing Opa1 resulted in decreased proliferation of type II NBs and mature INPs and loss of mature INPs, GMCs and neurons (Fig 8). Decreased Marf led to an increase in the numbers of GMCs due to less proliferation thereby leading to depletion of neurons in the type II NB lineage. Interestingly, mitochondrial outer membrane fusion ameliorated the defects in mitochondrial activity and differentiation caused by Opa1 and Marf depletion. Notch signaling regulated fused mitochondrial morphology in the type II NB. Notch signaling was decreased on mitochondrial fragmentation in Opa1 depleted type II NB lineages. Mitochondrial fusion in Notch depleted type II NB lineages led to suppression of differentiation defects. Here, we discuss our results in the following contexts: 1] the mechanisms by which Notch signaling gives rise to fused mitochondrial morphology, 2] the role of the mitochondrial morphology in mediating Notch signaling and 3] the role of mitochondrial fusion in differentiation in NBs.

Fig 8. Schematic summary for regulation of type II NB differentiation by Opa1 driven fused mitochondrial morphology.

Fig 8

Mitochondrial morphology is intermediate in state with some tubular mitochondria in the type II NBs. Notch receptor (red) is present on the plasma membrane in lineage cells and Notch signaling as seen by E(spl)mγ-GFP (green) is active in type II NBs and mature INPs. Loss of mitochondrial fusion by depletion of Opa1 leads to mitochondrial fragmentation in type II NBs and mature INPs, cytoplasmic accumulation of Notch receptor (red) in type II NBs and mature INPs while it is reduced from the membrane of mature INP cells leading to decrease in INP numbers.

Regulation of mitochondrial fusion by Notch signaling

At the heart of the discussion on interaction between Notch signaling and mitochondrial morphology, lies an analysis of how Notch signaling regulates mitochondrial fusion and activity. Loss of su(H) also showed fragmented mitochondria similar to downregulation of Notch. In addition, mitochondrial fusion on Drp1SD overexpression alleviated the differentiation defects seen in type II NB lineages depleted of Notch. NICD and Su(H) are together required to activate nuclear targets downstream of Notch signaling. It is therefore possible that Notch regulates fused mitochondrial morphology through the canonical pathway by enhancing expression of fusion genes opa1 and marf or regulating activity of Opa1 and Marf by post translational modification and/or reducing expression or activity of Drp1. Notch signaling may also regulate mitochondrial activity by elevating components of the ETC. Recent studies show that NB tumors arising in brat RNAi, which also show upregulation of Notch signaling, show increased transcription of Opa1 and Marf and mitochondrial fusion. In addition oxidative metabolism increased resulting from an increase in expression of oxidative phosphorylation enzymes to support proliferation of these tumors [24,30]. Therefore an increase in Notch activity is likely to directly affect transcription of mitochondrial morphology and oxidative phosphorylation proteins. Change in density of mitochondria by Notch signaling is also achievable by affecting the autophagy pathway [14]. It remains to be tested whether depletion of Notch leads to inhibition of transcription of mitochondrial fusion proteins or increased transcription of mitochondrial fission proteins or an impact on metabolism by decreasing autophagy.

Impact of mitochondrial morphology on Notch signaling

Loss of Notch signaling leads to decrease in numbers of type II NBs and transition of type II NBs into type I NBs. Loss of Opa1 and Marf did not affect the numbers of type I and type II NBs. This observation suggests that mitochondrial fusion is not needed during Notch mediated formation of NBs during the embryonic stages. We found that proliferation of mature INPs is dependent upon Notch signaling driven mitochondrial fusion by Opa1. The Ase- Pros- immature INP numbers showed a variation but did not change in numbers in mitochondrial fusion depleted type II NB lineages. However, mitochondrial fusion is needed to produce healthy INPs that will mature, proliferate and differentiate to form GMCs. Further, a decrease in GMCs on Opa1 depletion occurs due to defects in division of the mature INPs. Decrease in neurons on Marf depletion arises due to decreased division rate of GMCs to neurons. Loss of mitochondrial fusion by depletion of Opa1 and Marf led to abrogation of mitochondrial activity.

How might loss of mitochondrial fusion and activity affect differentiation in the type II NB lineage? Mitochondrial morphology changes may affect levels of cell cycle regulatory molecules such as cyclin E thereby affecting Notch signaling [60,61]. This is likely to be a cause of changes in mitotic rates in the type II NB lineage. The decrease in mitotic type II NBs and mature INPs suggests a decrease in their division rate on Opa1 depletion. Marf depletion on the other hand gave an increase in dividing mature INPs. This increase in division rate of mature INPs and a decrease in division rate of GMCs causes their accumulation on Marf depletion. Further reduction in GMC proliferation rate causes depletion of Pros positive neurons on Marf depletion. Future analysis of changes in cell cycle regulatory molecules will enable us to tease apart the mechanistic reasons for differences in cell division rates on depletion of mitochondrial morphology proteins in the type II NB lineage.

Changes in mitochondrial morphology may also have an effect on the cell fate by regulating key metabolites (Choi et al. 2020; Galloway and Yoon 2013). Mitochondrial pyruvate carrier (MPC) in the inner mitochondrial membrane is involved in transport of pyruvate from cytoplasm to the mitochondrial matrix where pyruvate undergoes oxidation via tricarboxylic acid (TCA) cycle (McCommis and Finck 2015). MPC depletion in the intestinal stem cells (ISC) results in shift of metabolism from TCA to the glycolysis which further leads to increased ISC proliferation and loss of differentiation (Schell et al. 2017). In NBs, inhibition of complex I results in loss of neuronal diversity and increased dependence on glycolysis for ATP [23,28]. Almost all glycolytic and some TCA cycle enzymes are known to localize to the nucleus in several contexts where they influence the nuclear metabolism by regulating activity of different epigenetic modifiers and cell fate [68,69]. We observed severe differentiation defects upon loss of Opa1 in NB lineage. It is possible that the defects in the inner mitochondrial membrane due to Opa1 loss affect pyruvate transport into the mitochondria which further affect NB metabolic program and differentiation. It will be interesting to check whether pyruvate metabolism is affected in the mitochondrial morphology mutants.

Our observations show that Opa1 depleted type II NBs show a loss of Notch receptors on the plasma membrane and increase in endosomes in the type II NB and in the cells of the lineage. Notch signaling is decreased in Opa1 depleted type II NB lineages. Numb regulates inhibition of Notch signaling in INPs [30]. It is possible that sustained activity of Numb in INPs and mature INPs generated from NB proliferation leads to a decrease in Notch signaling in the mature INPs. Future experiments on the defects on Numb distribution in type II NBs will reveal a mechanistic link between mitochondrial morphology, activity and Notch signaling.

Notch signaling may also be affected by interaction between mitochondrial morphology and other upstream signaling pathways. Interestingly, our finding that Notch signaling maintains fused mitochondria in NBs is in striking contrast to recent literature in other systems where fused mitochondrial morphology has been correlated with loss of notch activity. In triple negative breast cancer (TNBC) Notch signaling enhances mitochondrial fission via drp1 [70]. In Drosophila ovarian posterior follicle cells, mitochondrial fusion induces an increase in mitochondrial membrane potential and loss of Notch signaling [18,19]. Loss of Opa1 in cardiomyocytes leads to decrease in differentiation due to enhanced Notch processivity [20]. It is interesting to speculate the reasons for observing tissue specific differences in the requirement of mitochondrial fusion for Notch signaling in differentiation. We had previously found that EGFR signaling regulates fragmented morphology for appropriate Notch signaling in Drosophila follicle cells [18,19]. It is likely that fragmented mitochondrial morphology leads to an interaction between EGFR and Notch signaling pathways in follicle cells and possibly other cell types such as cardiomyocytes and TNBCs where Notch signaling increases only on loss of mitochondrial membrane potential or fragmentation.

Role of mitochondrial fusion in Notch driven differentiation in NBs

Mitochondrial fusion is coincident with elaborate cristae organization, increased activity and increased oxidative phosphorylation [47,71,72]. Drp1 mutant expression led to the formation of clustered mitochondria on one side of the nucleus, but did not show any defect on NB differentiation implying that Drp1 is dispensable for NB formation and differentiation. Interestingly, Drp1 loss driven mitochondrial hyperfusion could suppress the mitochondrial activity and differentiation defects in Opa1 and Marf depleted type II NBs. Mitochondrial fragmentation and loss of mitochondrial membrane potential is likely to cause a reduction in ATP [73]. However, ATP depletion has been reported only on combined loss of oxidative phosphorylation and glycolysis and brat RNAi driven tumors rely on NAD+ metabolism rather than ATP synthesis [2224]. Since we did not see ATP stress in Opa1 and Marf depleted type II NBs, it is interesting to speculate that other mitochondrial functions dependent upon mitochondrial activity from oxidative phosphorylation are important for type II NB differentiation. Indeed mitochondrial activity may give rise to changes in calcium buffering and key metabolites [74] thereby affecting Notch signaling in NBs and lineage cells depleted of Opa1 and Marf.

Since depletion of inner mitochondrial membrane protein Opa1 affected differentiation to a greater extent as compared to Marf, it is possible that organization of the mitochondrial ETC complexes and cristae architecture in addition to fusion are crucial for type II NB proliferation and differentiation. Organization of the cristae architecture independent of oxidative phosphorylation has been previously shown to be important for Drosophila germ line stem cell differentiation [75]. Fusion of the outer mitochondrial membrane may restore the inner membrane organisation and increase mitochondrial activity needed in type II NB proliferation and differentiation. Recent evidence suggests that neurodegeneration defects caused by depletion of oxidative phosphorylation in Purkinje neurons can be completely rescued by mitochondrial fusion produced by overexpression of Mfn [76]. NBs deficient of the mitochondrial ETC lead to fragmentation [23] and it will be interesting to probe if fusion of mitochondria in ETC mutants will also mitigate the differentiation defect.

In summary, we find a role for mitochondrial fusion in regulation of Notch signaling in type II NB differentiation. Future studies on the mechanistic link between mitochondrial activity, change in metabolite status and Notch signaling in diverse contexts will give insight into the interaction between Notch signaling and mitochondrial morphology in a tissue specific manner. Our studies motivate an analysis of mechanisms that regulate the interaction between mitochondrial fusion or inner membrane architecture and signaling during development and differentiation at large.

Materials and methods

Fly genetics

Fly crosses were performed in standard cornmeal agar medium and raised 29°C. The following fly lines were used in this study: pntP1-Gal4,UAS-mCD8-GFP (pnt-Gal4, mCD8-GFP, Jurgen Knoblich, IMP, Vienna, Austria), elav-Gal4, prospero-Gal4, inscuteable-Gal4, scabrous-Gal4, worniu-Gal4, opa1 RNAi (Bloomington stock number BL32358), opa1 RNAi (Ming Guo, UCLA), marf RNAi (Ming Guo, UCLA, [35]), marf RNAi (BL31157), opa1 RNAi2 (BL67159), opa1 RNAi VDRC (VDRC TID 330266), marf RNAi2 (BL67158, [77]), marf RNAi VDRC (VDRC TID 105261), drp1 RNAi (BL51483), drp1 RNAi (VDRC44155), FRT40A drp1KG, UASp-Drp1S193D (Drp1SD in the UASp vector, GTPase domain mutant, acts as a dominant negative on overexpression, made in the Richa Rikhy lab [31]), notch RNAi (BL31383), su(H) RNAi (BL67928), UAS-NotchFL (BL52309) and UAS-Nintra (LS Shashidhara, IISER, Pune, India), hSOD1 mutant (BL33607), mCherry RNAi (BL35785), UASp-mRFP (second chromosome, Richa Rikhy lab stock), mito-GFP (BL8442), E(spl)mγ-GFP (Rohit Joshi, CDFD, Hyderabad, India). Drp1SD;opa1 RNAi, Drp1SD;marf RNAi, notch RNAi /CyOGFP; opa1 RNAi /TM3SerGFP, notch RNAi/CyOGFP; marf RNAi/TM3SerGFP, FRT40A;opa1 RNAi, FRT40A drp1KG;opa1 RNAi lines were generated using standard genetic crosses. worniu-Gal4,UAS-mCD8-GFP (wor-Gal4) was used to express transgenes in all the larval NBs in the third instar larval brain and pointed-Gal4 (pnt-Gal4) was used to express transgenes in the type II NBs in the larval brain. pnt-Gal4; mCD8-GFP crossed to Drp1SD;mCherry RNAi, mRFP;opa1 RNAi and mRFP;marf RNAi were used as controls for estimating mitochondrial morphology and differentiation of cells in the type II NB lineage in the combinations Drp1SD;opa1 RNAi and Drp1SD;marf RNAi.

MARCM clones for mitochondrial morphology protein mutants

MARCM clones were generated for drp1KG;opa1 RNAi and drp1KG;marf RNAi together by the crossing hs-FLP; FRT 40A tub-Gal80, tub-Gal4, UAS-mCD8-GFP with FRT40A drp1KG, FRT40A;opa1 RNAi and FRT40A drp1KG;marf RNAi respectively. First instar larvae were heat shocked at 37°C for 15 mins and third instar larvae obtained were checked for the presence of GFP positive clones and dissected and stained with ATPb and imaged using confocal microscopy to assess mitochondrial distribution in type II NBs.

Immunostaining of larval brain

Wandering third instar larvae were dissected in Schneider’s medium and immediately fixed in 4% PFA solution for 25 minutes at room temperature (RT). The brains were washed subsequently with 1X PBS with 0.1% Triton X-100 (PBST) for 30 minutes at RT. They were blocked with 1% BSA for 1hr at RT. The brains were stained with the appropriate primary antibody overnight at 4°C. They were then washed 3 times with 0.1% PBST (first wash for 20 minutes and remaining for 10 minutes each). An appropriate fluorescently coupled secondary antibody was added for 1hr at RT followed by three washes with 0.1% PBST (first wash for 20 min and remaining for 10 min each) and mounted in Slow-Fade Gold (Molecular Probes).

The following dilutions were used for the primary antibodies: chicken anti-GFP (1:1000, Invitrogen), mouse-anti- ATPβ (1:200, Abcam), rabbit anti-Deadpan (1:800, Yuh-Nung Jan, UCSF, USA), rat-anti-Deadpan (1:150, Abcam), mouse-anti- Prospero (1:25, DSHB), rat-anti-Miranda (1:600, Abcam and Chris Doe, University of Oregon, USA), rat-anti-Ase (1:1000, Jurgen Knoblich, IMBA, Vienna, Austria), rabbit anti-Ase (1:10000, Yuh-Nung Jan, UCSF, USA), rabbit-anti-Cytochrome C (1:200, Cell Signaling), rabbit-anti-cleaved Caspase 3 (1:100, Cell Signaling), rabbit anti-phosphohistone 3 (1:500, Invitrogen), mouse anti-phosphohistone 3 (1:500, Invitrogen), rabbit-anti-phosphoAMPK (1:200, Cell Signaling), mouse-anti-NICD (1:10, DSHB). Hoechst (1:1000, Molecular Probes) was used to label DNA. Fluorescently coupled secondary antibodies (Molecular Probes): anti-Chicken 488, anti-Rat 568/633/647, anti-Rabbit 568, anti-Mouse 568/633 were used in 1:1000 dilution.

DHE uptake for live imaging of ROS

Dissected third instar larval brains were treated with Dihydroethidium (DHE) (1:1000 of a 30mM stock, Molecular Probes) in Schneider’s medium for 15 minutes at RT and then washed with Schneider’s medium for 10 min. Brains were mounted in LabTek chambers containing Schneider’s medium and imaged immediately using Zeiss LSM 710 with a 63x/1.4NA oil objective using a DPSS (561 nm) laser and dihydroethidium-1 filter settings in the Zeiss2010 software. The laser power, acquisition speed, frame size and gain were kept the same for different genotypes. The laser power and gain were adjusted to keep the range of acquisition between 0–255 on an 8-BIT scale.

2-Deoxy glucose treatment

Third instar larval brains were treated with 500μM 2-DG in Schneider’s medium for 1hr. Control and treated brains were processed for pAMPK immunostaining as mentioned above. They were imaged at the same time with the same laser settings. The grey values increase in the 2-DG treated brains as compared to the DMSO controls.

Mitochondrial membrane potential estimation with TMRM in live brains

Third instar larval brains were dissected in Schneider’s medium. Then they were treated with Tetramethylrhodamine, methyl ester (TMRM) (100nM, Thermo fisher Scientific) for 30 mins at room temperature. Treated brains were mounted in a LabTek chamber containing Schneider’s medium and imaged immediately using Zeiss LSM710 with a 63x/1.4NA oil objective. A DPSS (561 nm) laser and RFP/TRITC filter was used for the detection of TMRM signal. The mitochondrial fusion protein depleted type II NB lineages were imaged under the same laser settings and at the same time as controls. Percentage of type II NBs showing similar TMRM intensities to the representative images were shown on the image panel for each genotype.

Cell proliferation analysis by EdU assay

Third instar wandering larvae of selected genotypes were dissected in Schneider’s medium and incubated for 1hr in 10μM EdU (5-ethynyl-2´-deoxyuridine) solution at RT followed by fixation in 4%PFA for 25min. Next brains were washed twice, 5 min each, with 3% BSA in PBS. and then permeabilized in 0.3% PBST for 20min at RT. Brains were then incubated with anti-GFP antibody in 0.3% BSA for 3hrs. After primary antibody incubation, brains were washed twice 5 min each) with PBS and then treated with 0.3% PBST for 20 min. Click-iT reaction cocktail was made according to the manufacturer’s instruction. Alexa fluor 488 coupled anti-chicken antibody (1:1000, Molecular Probes) was added in reaction cocktail to detect GFP antibody added in the previous step. Brains were then treated with reaction cocktail for 30 min at RT followed by 3% BSA and 1X PBS wash for 5 min each. For DNA staining, brains were treated with Hoechst (1:1000) in 1X PBS for 10 min and then 5 min wash with 1XPBS and mounted in Slow-Fade Gold (Molecular probes) and subsequently imaged using Zeiss LSM710 with a 40x/1.4NA oil objective.

TUNEL assay for detection of apoptotic cells

Third instar wandering larvae were dissected in Schneider’s medium and fixed in 4% PFA for 25 mins followed by washing with 0.1% PBST for 20 mins at RT. Brains are then washed twice with 1XPBS for 2 min. The terminal transferase (TdT) reaction was performed as follows: First brains were treated with TdT reaction buffer and incubated for 10 min followed by treatment of freshly made TdT reaction buffer cocktail (TdT reaction buffer, 5-Ethynyl-dUTP, TdT) for 60 min at 37°C and at 500rpm. After the TdT reaction, brains were washed twice with 3% BSA at RT for 5 min. Then Click-iT reaction was performed by adding click iT reaction cocktail (Click-iT reaction buffer, Click-iT reaction buffer additive) for 30 min at RT. At this step samples were protected from light. Brains were washed with 3% BSA twice for 5 min after removing Click-iT reaction buffer cocktail and then incubated with Hoescht (1:1000) for DNA staining followed by washing with 1XPBS for 10 min. Samples mounted in Slow-Fade Gold (Molecular probes) and subsequently imaged using Zeiss LSM710 with a 40x/1.4NA oil objective and DPSS laser (561nm). Induction of apoptosis by the UAS-Hid line driven by pnt-Gal4 was used as positive control. TUNEL positive nuclei were counted and plotted using GraphPad Prism 5 software.

Microscopy and Image acquisition

Imaging of fixed samples using a confocal microscope

Confocal microscopy of fixed samples was done at room temperature using LSM710 or LSM780 inverted microscope (Carl Zeiss, Inc. and IISER Pune microscopy facility) with a Plan apochromat 40x 1.4NA and 63x 1.4NA oil objective. Images were acquired using the Zen2010 software at 1024x1024 pixels with an averaging of 4 and acquisition speed 7. Fluorescence intensity was kept within 255 on an 8-bit scale. Following lasers were used for the excitation of different fluorophores during fixed sample imaging: Diode laser for Hoescht, Argon laser line at 488 nm for Alexa Fluor 488, DPSS laser for Alexa Fluor 568, HeNe (633 nm) for Alexa Fluor 633 and Alexa Fluor 647. The representative image for each type II lineage in the figures is shown from the center of the lineage and comprises the maximum number of cells in the lineage.

Stimulated Emission-Depletion (STED) microscopy for imaging mitochondrial morphology

Super-resolution microscopy was done for visualizing mitochondrial morphology within type II NBs using the Leica TCS SP8 STED 3X Nanoscope with a 100x/1.4NA oil objective. Images were acquired using the LasX software at 1024x1024 pixels to keep pixel size 20-25nm, an averaging of 4, an acquisition speed of 200 and a zoom of 4.5. The Alexa Fluor 488 and 568 were excited with Argon 488 nm and Diode 561 nm lasers respectively and emission were collected with hybrid detectors for GFP and mitochondria labeled with ATPβ antibody respectively. The 561 nm excitation laser with the 660nm depletion laser was used for stimulated emission-depletion for visualizing mitochondria by super resolution. Fluorescence intensity was kept within 255 on an 8-bit scale using the LUT mode to avoid over-saturated pixels.

Image analysis and statistics

Neuroblasts number analysis

NBs in the central brain region of a single hemisphere were counted by marking with Miranda as a NB marker across different genotypes. Type II NBs were counted by using mCD8-GFP positive lineages expressed with pnt-Gal4. Non-parametric student’s t-test was performed for statistical analysis.

ROS intensity analysis

Fluorescence intensity of DHE uptake in type II NB (mCD8-GFP positive) of different genotypes along with their neighboring NB (mCD8-GFP positive) were quantified by drawing a region of interest using a free hand tool in ImageJ. Ratios of DHE fluorescence intensity of GFP positive NB to a neighboring GFP negative NB present in the same optical plane were computed for all the genotypes and normalized to the average of the control to represent on a 0–1 scale. The values were plotted using GraphPad Prism software. Non-parametric student’s t-test was performed for statistical analysis.

pH3 analysis

Total number of pH3 positive cells were counted in each type II NB lineage for control and RNAi and mutant allele expressing brains to estimate the number of mitotic cells in the lineage. Total numbers of pH3 positive NBs in the larval brain were quantified by numbers of NBs expressing pH3. Mitotic mature INPs were counted by performing Dpn staining in conjunction with pH3. Mitotic GMCs were analyzed by counting Ase, nuclear Pros and pH3 positive cells in type II lineage and plotted using GraphPad Prism software. Non-parametric student’s t-test was used for statistical analysis.

EdU analysis

All EdU positive cells across different planes were counted in a single type II lineage for control and RNAi and mutant expressing brains and plotted using GraphPad Prism software. Non-parametric student’s t-test was performed for statistical analysis.

Quantification of mature INPs, GMCs and neurons in type II NB lineages

The Ase and Pros negative cells adjacent to the type II NB in each lineage are immature INPs. Dpn positive cells are mature INPs. Ase staining marked immature INPs, mature INPs and GMCs. Dpn negative Ase positive cells distant from the NB and nearer to INPs are counted as GMCs in all sections in each type II NB lineage. Numbers of cells were plotted using GraphPad Prism software and non- parametric student’s t-test was performed for statistical analysis.

Young neurons at the base of the lineage do not have Ase and show high nuclear Pros expression [27,78]. These bright Pros positive cells were counted from all the optical planes of the type II NB lineage to estimate the numbers of young neurons arising as a result of division of GMCs. The boundary of the lineage was identified by staining them with anti-GFP to enhance the mCD8-GFP signal. The brightness and contrast tool in ImageJ was used to further ensure that the cells being counted belong to the same lineage.

For estimating Pros positive cells in larval NBs of the type I and type II lineage together labeled with worniu-Gal4,UAS-mCD8-GFP, the maximum intensity optical plane was selected from anterior and posterior regions. We obtained the average area for each Pros positive nucleus from 5 Pros positive cells in each sample. The total Pros positive area was determined by using the threshold tool in ImageJ. To extract the number of Pros positive cells, we divided the total area by the average area of a single cell positive for Pros.

TMRM analysis

Average TMRM intensities were computed from GFP positive type II NB using a thresholding tool in the ImageJ across all the genotypes. Average intensities were then normalised to the average of the control imaged at the same laser settings. Relative intensities were then plotted using GraphPad Prism software.

pAMPK analysis

Average pAMPK intensities were obtained from GFP positive type II NBs from different genotypes and neighboring GFP negative NBs. pAMPK fluorescence was plotted as a ratio to the neighboring control cells by using GraphPad Prism software. Larval brain treatment with 2-DG and DMSO, the brains were imaged at the same time with the same laser power and gain settings. The 2-DG treated brains showed an overall increase in antibody fluorescence and the intensity in the GFP positive type II NBs were expressed as a ratio to the average intensity of the control treated with DMSO.

NICD fluorescence estimation

Average NICD intensities in the cytoplasm were quantified by making a rectangular ROI in the type II NB cytoplasm of different genotypes using ImageJ and then plotted as a ratio to the fluorescence in the nucleus using GraphPad Prism software. Membrane NICD intensities in the type II NB lineage were quantified by drawing ROI on the cell membrane using mCD8-GFP as a reference. Normalized NICD intensities were plotted using GraphPad Prism software.

Mitochondrial morphology and area analysis

Brains of different genotypes were immunostained with ATPβ antibody or anti-GFP against mito-GFP to visualize mitochondria. Mitochondria appeared bead-like in control type II NBs. Mitochondria were qualitatively divided into 3 types of morphologies based on their appearance: intermediate, fused and fragmented in the type II NBs and in mature INPs [79]. A stacked histogram was plotted in Excel showing the distribution of mitochondrial morphology into these different types in Figs 1, 3, 6 and S10. The percentage phenotype that maximally occurred in each genotype is a part of images and the stacked histogram in Figs 1, 3, 6 and S10. Further, quantitative measurements for size in the form of area of mitochondria were done by using a thresholding tool in imageJ software from type II NBs. A region of interest was selected approximately in the middle of the type II NB (optical section with the highest diameter) where mitochondria are well separated. The size of the ROI was maintained the same across genotypes. Area of mitochondrial particles which were above size cut off of 0.12 μm2 were computed and plotted using GraphPad Prism software.

TUNEL analysis

TUNEL positive nuclei per central brain region or type II NB lineage were counted in lobes of control and opa1 RNAi and plotted using GraphPad Prism software. We induced apoptosis by expressing UAS-Hid with pnt-Gal4 as a positive control for TUNEL assay.

Supporting information

S1 Fig. Table showing analysis of mitochondrial morphology protein knockdown with different neuronal Gal4s.

Various Gal4 drivers were crossed with RNAi depletion lines and a Drp1 dominant negative mutant of mitochondrial morphology genes at 25 or 29°C and lethality or behavioral phenotype was recorded in the adult. worniu-Gal4 (wor-Gal4), inscuteable-Gal4, prospero-Gal4 and scabrous-Gal4 expresses the Gal4 in all NBs, pnt-Gal4 expresses in type II NBs and elav-Gal4 expresses in neurons. Adult flies from crosses with wor-Gal4 (25°C) and pnt-Gal4 (29°C) with opa1 RNAi and marf RNAi were sluggish and the numbers obtained were at the expected frequency, no lethality was seen at the pupal stage. elav-Gal4 crosses gave lethality and few adults emerged. The opa1 RNAi BL32358 and opa1 RNAi2 BL67158 gave stronger phenotypes as compared to opa1 RNAi Ming Guo lab with inscuteable-Gal4, prospero-Gal4, elav-Gal4 and scabrous-Gal4. The marf RNAi Ming Guo lab and marf RNAi2 BL67159 gave stronger phenotypes as compared to marf RNAi BL31157 with inscuteable-gal4, prospero-Gal4 and elav-Gal4. We chose opa1 RNAi BL32358, opa1 RNAi2 BL67158, marf RNAi Ming Guo lab and marf RNAi BL67159 for further analysis. The Drp1 RNAi from VDRC did not show phenotypes and the Drp1 (BL51483) gave inconsistent results, hence we used a lab generated construct overexpressing the GTPase domain mutant Drp1SD for further analysis.

(TIF)

S2 Fig. Depletion of mitochondrial fusion proteins Opa1 and Marf result in mitochondrial fragmentation.

A, B:Mitochondrial morphology and distribution in type II NBs (white dotted line, magnified area shown in the panel on the right) stained with ATPβ (red) antibody using STED super resolution microscopy is shown in representative images with zoomed inset in the right panel (A). Control (100% tubular, 75 NBs, 22 brains), opa1 RNAi2 (100% fragmented, 14,4), marf RNAi2 (100% fragmented, 14,4). Average mitochondrial area quantification from type II NBs (B) in control (10 type II NBs, 4 brains), opa1 RNAi2 (8,4), marf RNAi2 (5,3). Scale bar- 5μm. C: Clonal analysis of NB clones (green) expressing drp1KG allele show clustered mitochondria stained with ATPβ antibody (red). FRT40A drp1KG (8 NB clones), FRT40A;opa1 RNAi (13), FRT40A drp1KG;opa1 RNAi (13). D: Representative confocal images of mitochondria labeled with mito-GFP (green) in larval muscles. Expression of opa1 and marf RNAi by mhc-Gal4 shows smaller mitochondria while Drp1SD shows large mitochondria compared to control. Representative images from a minimum of 3 larvae are shown, the phenotype of smaller mitochondria is at 100% in muscle 6 and 7 of segment A2 and A3 in opa1 and marf RNAi and of larger mitochondria in Drp1SD overexpression. Scale bar-3μm.

(TIF)

S3 Fig. Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage.

A,C:Type II NB lineages (yellow dotted line) showing expression of mCD8-GFP (green) and Dpn (red, yellow arrows) (A). Quantification of Dpn positive mature INPs (C) in control (20 NB lineages, 5 brains), opa1 RNAi2 (19,4), marf RNAi2 (15,4). Scale bar- 10μm. B: Quantification of number of type II NBs in control, opa1 RNAi, marf RNAi, Drp1SD (n = 15 brains each). C,E:Type II lineages (pnt-Gal4, mCD8-GFP, green) showing Pros positive INPs (red, yellow arrows) (C, yellow arrows). Quantification of Pros positive young neurons (E) in control (28 NB lineages,8 brains), opa1 RNAi2 (19,4), marf RNAi2 (18,4). Scale bar- 10μm. F-G: Representative type II NB lineages showing reduced numbers of mature INPs and GMCs in opa1 RNAi from VDRC stock center. Quantification of mature INPs (G) in mCherry RNAi, opa1 RNAi (VDRC), marf RNAi (VDRC). Analysis of numbers of GMCs (Dpn- Ase+, yellow arrows) in type II NB lineage in mCherry RNAi (19 type II NB lineages, 6 Brains), opa1 RNAi (VDRC) (20,5), marf RNAi (VDRC) (12,5). B,D,E& G: Graphs show mean ± sd. Statistical analysis is done using an unpaired t-test. ns- non significant, ***- p<0.001.

(TIF)

S4 Fig. NB polarity and number are unaffected by knockdown of mitochondrial morphology proteins.

A, B: Representative confocal images of larval brain lobes stained for Miranda (red) show no change in NB number (A). Expression of opa1 RNAi, marf RNAi and Drp1SD was done by wor-Gal4. Quantification of NB number in larval brain lobes (B) of control (13 lobes,13 brains), opa1 RNAi (10,10), marf RNAi (10,10), Drp1SD (10,10). Scale bar- 50μm. C: Representative images showing apical Bazooka and basal Numb localization in control and mitochondrial dynamics mutants. Bazooka is present at the apical side (away from progenies) and Numb at the basal side (near the progenies) in dividing NBs of all genotypes. Scale bar- 10μm. D, E: Representative images of brain lobes showing reduced Pros positive cells in opa1 RNAi expressed with wor-Gal4, mCD8-GFP (D). Analysis of bright Pros positive cells (E) in control (10 lobes,10 brains), opa1 RNAi (11,11), marf RNAi (7,7), Drp1SD (11,11). Scale bar- 50μm. B, E: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant, ***- p<0.001.

(TIF)

S5 Fig. Expression of mRFP does not perturb the severity of opa1 RNAi and marf RNAi phenotypes.

A, D: Representative confocal images of type II NB lineages showing expression of Dpn (grey scale) (A) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of Dpn positive cells (yellow arrows) (D) in opa1 RNAi (21 Type II NB lineages, 6 Brains), mRFP;opa1 RNAi (25,4), marf RNAi (15,8), mRFP;marf RNAi (15,3). Scale bar- 10μm. B, E: Representative confocal images of type II NB lineages showing Ase positive cells (grey scale) (B) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of Ase positive cells (yellow arrows) (E) in opa1 RNAi (12 Type II NB lineages, 5 Brains), mRFP;opa1 RNAi (16,3), marf RNAi (10,4), mRFP;marf RNAi (15,3). Scale bar- 10μm. C, F: Representative confocal images of type II NB lineages showing high levels of Pros expressing young neurons (grey scale) (C) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of brightly stained Pros positive young neurons (yellow arrows) (F) in opa1 RNAi (18 Type II NB lineages, 5 Brains), mRFP;opa1 RNAi (15,3), marf RNAi (15,5), mRFP;marf RNAi (13,3). Scale bar- 10μm. D-F: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant. Values for opa1 RNAi and marf RNAi are repeated from Fig 2 for comparison.

(TIF)

S6 Fig. Depletion of Opa1 does not increase pAMPK in type II NBs.

A, B: Representative images of type II NBs expressing opa1 and marf RNAi along with pnt-Gal4, mCD8-GFP did not show change in levels of pAMPK (pAMPK fluorescence is shown as a grey scale) (A). Brains of different genotypes were treated with 2-DG and were imaged for pAMPK fluorescence at the same time under the same imaging conditions. Type II NBs are marked by white dotted lines while lineages are marked by expression of mCD8-GFP (green). Analysis of pAMPK intensity normalised with neighboring control cells (B). +/+ (32 NBs,14 brains), opa1 RNAi (23,8), marf RNAi (33,8), DMSO (76,8), 2-DG (91,9). Scale bar- 10μm.

(TIF)

S7 Fig. Depletion of Opa1 shows increased ROS levels in the type II NB lineage.

A, B: Representative images showing increased levels of ROS (rainbow scale) in type II NB (position marked by white dotted line) using pnt-Gal4, mCD8-GFP with different genotypes (A). Analysis of relative DHE fluorescence as a ratio to neighboring cells (B) in type II NBs, +/+ (22 NBs,6 Brains), opa1 RNAi (17,8), marf RNAi (17,8), Drp1SD (9,5), hSOD1 mutant overexpression (13,3). Scale bar- 10μm.

(TIF)

S8 Fig. Depletion of Opa1 and Marf does not cause increase in the cleaved Caspase 3 levels and apoptosis in the brain.

A: Representative images of type II NB lineages (green) stained for cleaved caspase 3 and shown in heatmap. +/+ (for opa1 RNAi, 10 NB lineages, 6 brains), opa1 RNAi (9,6), Control (for marf RNAi, 24 Type II NB lineages, 6 Brains), marf RNAi (30,5). Scale bar- 10μm. B, C: Fluorescence confocal images of brain hemispheres showing no significant change in TUNEL positive nuclei (red, white arrows) (B) in opa1 RNAi expressed in all NBs with wor-Gal4. Scale bar- 50μm. Expression of hid shows a significant increase in TUNEL positive cells when expressed with pnt-Gal4, mCD8-GFP in the type II NB lineage. Quantification of TUNEL positive nuclei (C) in wor-Gal4/+ (3 brains), wor-Gal4 opa1 RNAi (4), pnt-Gal4 UAS-hid reaper (5). Statistical analysis was performed using unpaired t-test. ns- non significant, ***- p<0.0001.

(TIF)

S9 Fig. Analysis of proliferation in NBs depleted of Opa1 and Marf.

A-B: Representative confocal images of larval brain lobes showing reduction of pH3 positive NBs upon loss of Opa1 (A). Analysis of numbers of pH3 positive NBs (yellow arrows) in larval brain lobe in control (8 brain lobes), opa1 RNAi (9), marf RNAi (6). Scale bar- 50μm. C: Quantification of total number of pH3 positive cells, and percentage of dividing mature INPs in type II NB lineages in mCherry RNAi (33 Type II NB lineages,7 brains), Drp1SD;mCherry RNAi (24,6), opa1 (33,6, Drp1SD;opa1 RNAi (26,8), marf RNAi (33,8), Drp1SD;marf RNAi (15,5). D: Representative images of type II NB lineages labeled with CD8-GFP (green), Pros (blue), Ase (red), pH3 (grey) showing reduced mitotic GMCs (yellow arrows, pH3+light Pros+Ase+) in marf RNAi (in support of graph presented in Fig 5D). Scale bar- 10μm.

(TIF)

S10 Fig. Notch signaling regulates fused mitochondrial morphology in INPs and muscle cells.

A: Representative confocal images of type II NB lineage (yellow dotted line) showing expression of mCD8-GFP (green) and Dpn (red) in the NBs. Note that Dpn is present in the NB and in the mature INPs in the lineage +/+ (39 Type II NBs, 5 brains), NotchFL (>100, 5). B: Representative confocal images of type II NB lineage (yellow dotted line) showing expression of mCD8-GFP (green) and Ase (red) in the type II NB lineage. Note that Ase is not present in the NB but present in the lineage +/+ (31 Type II NBs, 5 brains), NotchFL (>100, 5). C-D: Larval brain lobes show suppression of Notch mediated NB hyper proliferation on depletion of Opa1 and Marf (C). Quantification of NB number (D) in pnt-Gal4, UAS-mCD8-GFP control (14 lobes), NotchFL (11), NotchFL;opa1 RNAi (9), NotchFL;marf RNAi (9). Scale bar- 50μm. E-F: Confocal images showing mitochondria (red, stained with ATPβ) in mature INPs of type II NBs expressing mCherry RNAi (40 mature INPs, 5 brains, 8 lineages, 75% intermediate), notch RNAi (49 mature INPs, 4 brains, 10 lineages, 69% fragmented), su(H) RNAi (11 mature INPs, 3 brains, 4 lineages, 81% fragmented) and NFL (68 mature INPs, 4 brains, 13 lineages, 69% clustered). The control cohort is the same as that used in Fig 1. Graph shows the distribution of mitochondria into fragmented, intermediate and clustered in the form of a stacked histogram (F). The percentage documented on each bar in the histogram is for the group that is seen at the maximum extent. Scale bar- 2.7μm. G: Representative confocal images of mitochondria labeled with mito-GFP in muscle cells showing smaller mitochondria in notch and su(H) RNAi and larger mitochondria on Nintra overexpression. The image for control mCherry RNAi is repeated from S2 Fig for comparison. Representative images from a minimum of 3 larvae are shown, the phenotype of smaller mitochondria is at 100% in muscle 6 and 7 of segment A2 and A3 in notch and su(H) RNAi and of larger mitochondria in Nintra overexpression. Scale bar-3μm.

(TIF)

S1 Data. File containing data underlying the plots in the Fig 1.

(XLSX)

S2 Data. File containing data underlying the plots in the Fig 2.

(XLSX)

S3 Data. File containing data underlying the plots in the Fig 3.

(XLSX)

S4 Data. File containing data underlying the plots in the Fig 4.

(XLSX)

S5 Data. File containing data underlying the plots in the Fig 5.

(XLSX)

S6 Data. File containing data underlying the plots in the Fig 6.

(XLSX)

S7 Data. File containing data underlying the plots in the Fig 7.

(XLSX)

S8 Data. File containing data underlying the plots in the S2 Fig.

(XLSX)

S9 Data. File containing data underlying the plots in the S3 Fig.

(XLSX)

S10 Data. File containing data underlying the plots in the S4 Fig.

(XLSX)

S11 Data. File containing data underlying the plots in the S5 Fig.

(XLSX)

S12 Data. File containing data underlying the plots in the S6 Fig.

(XLSX)

S13 Data. File containing data underlying the plots in the S7 Fig.

(XLSX)

S14 Data. File containing data underlying the plots in the S8 Fig.

(XLSX)

S15 Data. File containing data underlying the plots in the S9 Fig.

(XLSX)

S16 Data. File containing data underlying the plots in the S10 Fig.

(XLSX)

Acknowledgments

We thank the RR lab members for discussions on this project and feedback on the manuscript. We thank the Drosophila facility and microscopy facility at IISER, Pune, India for support throughout this project. We thank Juergen Knoblich (IMP, Vienna) for the rat anti-Asense antibody and Chris Doe for the rat anti-Miranda antibody (University of Oregon, USA).

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

RR received the following funding for the study. This study is funded by the Department of Biotechnology, India (http://dbtindia.gov.in/) by the project code BT/PR18898/MED/122/19/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Xu X, Duan S, Yi F, Ocampo A, Liu G-H, Izpisua Belmonte JC. Mitochondrial regulation in pluripotent stem cells. Cell Metab. 2013;18: 325–332. doi: 10.1016/j.cmet.2013.06.005 [DOI] [PubMed] [Google Scholar]
  • 2.Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells. 2010;28: 721–733. doi: 10.1002/stem.404 [DOI] [PubMed] [Google Scholar]
  • 3.Suhr ST, Chang EA, Tjong J, Alcasid N, Perkins GA, Goissis MD, et al. Mitochondrial rejuvenation after induced pluripotency. PLoS One. 2010;5: e14095. doi: 10.1371/journal.pone.0014095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, et al. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol. 2017;19: 1027–1036. doi: 10.1038/ncb3593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol. 2014;15: 243–256. doi: 10.1038/nrm3772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018;62: 341–360. doi: 10.1042/EBC20170104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Westermann B. Molecular machinery of mitochondrial fusion and fission. J Biol Chem. 2008;283: 13501–13505. doi: 10.1074/jbc.R800011200 [DOI] [PubMed] [Google Scholar]
  • 8.Hoppins S, Lackner L, Nunnari J. The machines that divide and fuse mitochondria. Annu Rev Biochem. 2007;76: 751–780. doi: 10.1146/annurev.biochem.76.071905.090048 [DOI] [PubMed] [Google Scholar]
  • 9.Meeusen S, DeVay R, Block J, Cassidy-Stone A, Wayson S, McCaffery JM, et al. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell. 2006;127: 383–395. doi: 10.1016/j.cell.2006.09.021 [DOI] [PubMed] [Google Scholar]
  • 10.Olichon A, Guillou E, Delettre C, Landes T, Arnauné-Pelloquin L, Emorine LJ, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta. 2006;1763: 500–509. doi: 10.1016/j.bbamcr.2006.04.003 [DOI] [PubMed] [Google Scholar]
  • 11.Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126: 177–189. doi: 10.1016/j.cell.2006.06.025 [DOI] [PubMed] [Google Scholar]
  • 12.Cogliati Sara, Jose A Enriquez Luca Scorrano. Mitochondrial Cristae: Where Beauty Meets Functionality.—PubMed—NCBI. Trends in Biochemical Science. 2016;41: 261–273. [DOI] [PubMed] [Google Scholar]
  • 13.Rambold AS, Kostelecky B, Lippincott-Schwartz J. Fuse or die: Shaping mitochondrial fate during starvation. Commun Integr Biol. 2011;4: 752–754. doi: 10.4161/cib.17667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 2011;13: 589–598. doi: 10.1038/ncb2220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rolland SG, Motori E, Memar N, Hench J, Frank S, Winklhofer KF, et al. Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion. Proc Natl Acad Sci U S A. 2013;110: E2967–76. doi: 10.1073/pnas.1303872110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tondera D, Grandemange S, Jourdain A. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 2009. Available: https://www.embopress.org/doi/abs/10.1038/emboj.2009.89 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yamamoto S, Charng W-L, Bellen HJ. Endocytosis and intracellular trafficking of Notch and its ligands. Curr Top Dev Biol. 2010;92: 165–200. doi: 10.1016/S0070-2153(10)92005-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tomer D, Chippalkatti R, Mitra K, Rikhy R. ERK regulates mitochondrial membrane potential in fission deficient Drosophila follicle cells during differentiation. Dev Biol. 2018;434: 48–62. doi: 10.1016/j.ydbio.2017.11.009 [DOI] [PubMed] [Google Scholar]
  • 19.Mitra K, Rikhy R, Lilly M, Lippincott-Schwartz J. DRP1-dependent mitochondrial fission initiates follicle cell differentiation during Drosophila oogenesis. J Cell Biol. 2012;197: 487–497. doi: 10.1083/jcb.201110058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kasahara A, Cipolat S, Chen Y, Dorn GW 2nd, Scorrano L. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science. 2013;342: 734–737. doi: 10.1126/science.1241359 [DOI] [PubMed] [Google Scholar]
  • 21.Khacho M, Clark A, Svoboda DS, Azzi J, MacLaurin JG, Meghaizel C, et al. Mitochondrial Dynamics Impacts Stem Cell Identity and Fate Decisions by Regulating a Nuclear Transcriptional Program. Cell Stem Cell. 2016;19: 232–247. doi: 10.1016/j.stem.2016.04.015 [DOI] [PubMed] [Google Scholar]
  • 22.Homem CCF, Steinmann V, Burkard TR, Jais A, Esterbauer H, Knoblich JA. Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells. Cell. 2014;158: 874–888. doi: 10.1016/j.cell.2014.06.024 [DOI] [PubMed] [Google Scholar]
  • 23.van den Ameele J, Brand A. Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation. eLife. 2019. doi: 10.7554/eLife.47887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bonnay F, Veloso A, Steinmann V, Köcher T, Abdusselamoglu MD, Bajaj S, et al. Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis. Cell. 2020;182: 1490–1507.e19. doi: 10.1016/j.cell.2020.07.039 [DOI] [PubMed] [Google Scholar]
  • 25.Gallaud E, Pham T, Cabernard C. Drosophila melanogaster Neuroblasts: A Model for Asymmetric Stem Cell Divisions. In: Tassan J-P, Kubiak JZ, editors. Asymmetric Cell Division in Development, Differentiation and Cancer. Cham: Springer International Publishing; 2017. pp. 183–210. doi: 10.1007/978-3-319-53150-2_8 [DOI] [PubMed] [Google Scholar]
  • 26.Homem CCF, Knoblich JA. Drosophila neuroblasts: a model for stem cell biology. Development. 2012;139: 4297–4310. doi: 10.1242/dev.080515 [DOI] [PubMed] [Google Scholar]
  • 27.Bayraktar OA, Boone JQ, Drummond ML, Doe CQ. Drosophila type II neuroblast lineages keep Prospero levels low to generate large clones that contribute to the adult brain central complex. Neural Dev. 2010;5: 26. doi: 10.1186/1749-8104-5-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Samuels TJ, Arava Y, Järvelin AI, Robertson F, Lee JY, Yang L, et al. Neuronal upregulation of Prospero protein is driven by alternative mRNA polyadenylation and Syncrip-mediated mRNA stabilisation. Biol Open. 2020;9: bio049684. doi: 10.1242/bio.049684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Li X, Xie Y, Zhu S. Notch maintains Drosophila type II neuroblasts by suppressing expression of the Fez transcription factor Earmuff. Development. 2016;143: 2511–2521. doi: 10.1242/dev.136184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bowman SK, Rolland V, Betschinger J, Kinsey KA, Emery G, Knoblich JA. The tumor suppressors Brat and Numb regulate transit-amplifying neuroblast lineages in Drosophila. Dev Cell. 2008;14: 535–546. doi: 10.1016/j.devcel.2008.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chowdhary S, Madan S, Tomer D, Mavrakis M, Rikhy R. Mitochondrial morphology and activity regulate furrow ingression and contractile ring dynamics in Drosophila cellularization. Mol Biol Cell. 2020; mbcE20030177. doi: 10.1091/mbc.E20-03-0177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sen A, Damm VT, Cox RT. Drosophila clueless is highly expressed in larval neuroblasts, affects mitochondrial localization and suppresses mitochondrial oxidative damage. PLoS One. 2013;8: e54283. doi: 10.1371/journal.pone.0054283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhu S, Barshow S, Wildonger J, Jan LY, Jan Y-N. Ets transcription factor Pointed promotes the generation of intermediate neural progenitors in Drosophila larval brains. Proc Natl Acad Sci U S A. 2011;108: 20615–20620. doi: 10.1073/pnas.1118595109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Trevisan T, Pendin D, Montagna A, Bova S, Ghelli AM, Daga A. Manipulation of Mitochondria Dynamics Reveals Separate Roles for Form and Function in Mitochondria Distribution. Cell Rep. 2018;23: 1742–1753. doi: 10.1016/j.celrep.2018.04.017 [DOI] [PubMed] [Google Scholar]
  • 35.Deng H, Dodson MW, Huang H, Guo M. The Parkinson’s disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A. 2008;105: 14503–14508. doi: 10.1073/pnas.0803998105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Macchi M, El Fissi N, Tufi R, Bentobji M, Liévens J-C, Miguel Martins L, et al. The Drosophila inner-membrane protein PMI controls crista biogenesis and mitochondrial diameter. J Cell Sci. 2013;126: 814–824. doi: 10.1242/jcs.115675 [DOI] [PubMed] [Google Scholar]
  • 37.Son JM, Sarsour EH, Kakkerla Balaraju A, Fussell J, Kalen AL, Wagner BA, et al. Mitofusin 1 and optic atrophy 1 shift metabolism to mitochondrial respiration during aging. Aging Cell. 2017;16: 1136–1145. doi: 10.1111/acel.12649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Rikhy R, Kamat S, Ramagiri S, Sriram V, Krishnan KS. Mutations in dynamin-related protein result in gross changes in mitochondrial morphology and affect synaptic vesicle recycling at the Drosophila neuromuscular junction. Genes Brain Behav. 2007;6: 42–53. doi: 10.1111/j.1601-183X.2006.00218.x [DOI] [PubMed] [Google Scholar]
  • 39.Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell. 2001;12: 2245–2256. doi: 10.1091/mbc.12.8.2245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol. 1998;143: 351–358. doi: 10.1083/jcb.143.2.351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Aldridge AC, Benson LP, Siegenthaler MM, Whigham BT, Stowers RS, Hales KG. Roles for Drp1, a dynamin-related protein, and milton, a kinesin-associated protein, in mitochondrial segregation, unfurling and elongation during Drosophila spermatogenesis. Fly. 2007;1: 38–46. doi: 10.4161/fly.3913 [DOI] [PubMed] [Google Scholar]
  • 42.Insolera R, Lőrincz P, Wishnie AJ, Juhász G, Collins CA. Mitochondrial fission, integrity and completion of mitophagy require separable functions of Vps13D in Drosophila neurons. doi: 10.1101/2020.01.21.914523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wang Z-H, Clark C, Geisbrecht ER. Analysis of mitochondrial structure and function in the Drosophila larval musculature. Mitochondrion. 2016;26: 33–42. doi: 10.1016/j.mito.2015.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dorn GW 2nd, Clark CF, Eschenbacher WH, Kang M-Y, Engelhard JT, Warner SJ, et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ Res. 2011;108: 12–17. doi: 10.1161/CIRCRESAHA.110.236745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Patten DA, Wong J, Khacho M, Soubannier V, Mailloux RJ, Pilon-Larose K, et al. OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand. EMBO J. 2014;33: 2676–2691. doi: 10.15252/embj.201488349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Quintana-Cabrera R, Quirin C, Glytsou C, Corrado M, Urbani A, Pellattiero A, et al. The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function. Nat Commun. 2018;9: 3399. doi: 10.1038/s41467-018-05655-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Cogliati S, Enriquez JA, Scorrano L. Mitochondrial Cristae: Where Beauty Meets Functionality. Trends Biochem Sci. 2016;41: 261–273. doi: 10.1016/j.tibs.2016.01.001 [DOI] [PubMed] [Google Scholar]
  • 48.Otera H, Miyata N, Kuge O, Mihara K. Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling. J Cell Biol. 2016;212: 531–544. doi: 10.1083/jcb.201508099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Deng H, Takashima S, Paul M, Guo M, Hartenstein V. Mitochondrial dynamics regulates Drosophila intestinal stem cell differentiation. Cell Death Discov. 2018;4: 17. doi: 10.1038/s41420-018-0083-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552: 50–59. doi: 10.1016/j.ab.2017.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chowdhary S, Tomer D, Dubal D, Sambre D, Rikhy R. Analysis of mitochondrial organization and function in the Drosophila blastoderm embryo. Sci Rep. 2017;7: 5502. doi: 10.1038/s41598-017-05679-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Grahame Hardie D. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8: 774. doi: 10.1038/nrm2249 [DOI] [PubMed] [Google Scholar]
  • 53.Ježek J, Cooper KF, Strich R. Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression. Antioxid Redox Signal. 2018;7. doi: 10.3390/antiox7010013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.H. -U. Simon H, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5: 415–418. doi: 10.1023/a:1009616228304 [DOI] [PubMed] [Google Scholar]
  • 55.Tang S, Le PK, Tse S, Wallace DC, Huang T. Heterozygous Mutation of Opa1 in Drosophila Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production. PLoS One. 2009;4: e4492. doi: 10.1371/journal.pone.0004492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Watson MR, Lagow RD, Xu K, Zhang B, Bonini NM. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem. 2008;283: 24972–24981. doi: 10.1074/jbc.M804817200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A. 2002;99: 1259–1263. doi: 10.1073/pnas.241655498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Liu K, Shu D, Song N, Gai Z, Yuan Y, Li J, et al. The role of cytochrome c on apoptosis induced by Anagrapha falcifera multiple nuclear polyhedrosis virus in insect Spodoptera litura cells. PLoS One. 2012;7: e40877. doi: 10.1371/journal.pone.0040877 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863: 2977–2992. doi: 10.1016/j.bbamcr.2016.09.012 [DOI] [PubMed] [Google Scholar]
  • 60.Parker D, Iyer A, Shah S, Moran A, Hjelmeland A, Basu MK, et al. A novel mitochondrial pool of Cyclin E, regulated by Drp1, is linked to cell density dependent cell proliferation. Journal of Cell Science. 2015. doi: 10.1242/jcs.172429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chen H, Chan DC. Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells. Cell Metab. 2017;26: 39–48. doi: 10.1016/j.cmet.2017.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wang H, Somers GW, Bashirullah A, Heberlein U, Yu F, Chia W. Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts. Genes Dev. 2006;20: 3453–3463. doi: 10.1101/gad.1487506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Simon F, Fichelson P, Gho M, Audibert A. Notch and Prospero repress proliferation following cyclin E overexpression in the Drosophila bristle lineage. PLoS Genet. 2009;5: e1000594. doi: 10.1371/journal.pgen.1000594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Weng M, Golden KL, Lee C-Y. dFezf/Earmuff maintains the restricted developmental potential of intermediate neural progenitors in Drosophila. Dev Cell. 2010;18: 126–135. doi: 10.1016/j.devcel.2009.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Zhang H, Menzies KJ, Auwerx J. The role of mitochondria in stem cell fate and aging. Development. 2018;145. doi: 10.1242/dev.143420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Ma K, Chen G, Li W, Kepp O, Zhu Y, Chen Q. Mitophagy, Mitochondrial Homeostasis, and Cell Fate. Front Cell Dev Biol. 2020;8: 3184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Bahat A, Gross A. Mitochondrial plasticity in cell fate regulation. J Biol Chem. 2019;294: 13852–13863. doi: 10.1074/jbc.REV118.000828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Boukouris AE, Zervopoulos SD, Michelakis ED. Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. Trends Biochem Sci. 2016;41: 712–730. doi: 10.1016/j.tibs.2016.05.013 [DOI] [PubMed] [Google Scholar]
  • 69.Nagaraj R, Sharpley MS, Chi F, Braas D, Zhou Y, Kim R, et al. Nuclear Localization of Mitochondrial TCA Cycle Enzymes as a Critical Step in Mammalian Zygotic Genome Activation. Cell. 2017;168: 210–223.e11. doi: 10.1016/j.cell.2016.12.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Chen L, Zhang J, Lyu Z, Chen Y, Ji X, Cao H, et al. Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells. Cell Death Dis. 2018;9: 1050. doi: 10.1038/s41419-018-1083-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta. 2012;1817: 1833–1838. doi: 10.1016/j.bbabio.2012.02.033 [DOI] [PubMed] [Google Scholar]
  • 72.Yao C-H, Wang R, Wang Y, Kung C-P, Weber JD, Patti GJ. Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation. Elife. 2019;8. doi: 10.7554/eLife.41351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005;280: 26185–26192. doi: 10.1074/jbc.M503062200 [DOI] [PubMed] [Google Scholar]
  • 74.Parekh AB. Mitochondrial regulation of intracellular Ca2+ signaling: more than just simple Ca2+ buffers. News Physiol Sci. 2003;18: 252–256. doi: 10.1152/nips.01458.2003 [DOI] [PubMed] [Google Scholar]
  • 75.Teixeira FK, Sanchez CG, Hurd TR, Seifert JRK, Czech B, Preall JB, et al. ATP synthase promotes germ cell differentiation independent of oxidative phosphorylation. Nat Cell Biol. 2015;17: 689–696. doi: 10.1038/ncb3165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Motori E, Atanassov I, Kochan SMV, Folz-Donahue K, Sakthivelu V, Giavalisco P, et al. Neuronal metabolic rewiring promotes resilience to neurodegeneration caused by mitochondrial dysfunction. Sci Adv. 2020;6: eaba8271. doi: 10.1126/sciadv.aba8271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sandoval H, Yao C-K, Chen K, Jaiswal M, Donti T, Lin YQ, et al. Mitochondrial fusion but not fission regulates larval growth and synaptic development through steroid hormone production. Elife. 2014;3. doi: 10.7554/eLife.03558 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Jiang Y, Reichert H. Drosophila neural stem cells in brain development and tumor formation. J Neurogenet. 2014;28: 181–189. doi: 10.3109/01677063.2014.898639 [DOI] [PubMed] [Google Scholar]
  • 79.Cao X, Wang H, Wang Z, Wang Q, Zhang S, Deng Y, et al. In vivo imaging reveals mitophagy independence in the maintenance of axonal mitochondria during normal aging. Aging Cell. 2017;16: 1180–1190. doi: 10.1111/acel.12654 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Hongyan Wang

20 Jan 2021

Dear Dr Rikhy,

Thank you very much for submitting your Research Article entitled 'Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Hongyan Wang, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In this study, Dubal et al. studied potential roles of mitochondria dynamics in normal development of Drosophila type II neuroblast lineages. Specifically, they examined how knocking down mitochondria fusion/fission proteins Opa1, Marf, and Drp1 would affect the morphology of mitochondria in type II neuroblasts, generation of INPs and GMCs. Further, they examined functional relationship between Notch signaling and mitochondria dynamics in type II neuroblast lineage development. Previous studies have shown that oxidative phosphorylation is required for the growth/proliferation of Drosophila tumorigenic neuroblasts, but it seems still a little controversial whether oxidative phosphorylation is required for normal development of type II NB lineages. Therefore, it is interesting to directly examine whether manipulating mitochondrial fission and fusion, which are related with oxidative phosphorylation, would affect normal development of type II NB lineages. However, although this manuscript addresses an interesting question, I have quite a few major concerns that significantly dampen my enthusiasm for this work.

1. A recently published paper (Bonnay F, et al, Cell, 2020, 182: 1490) also examined how knockdown of Marf or Opa1 would affect normal type II neuroblast development and their results showed that knockdown of Marf or Opa1 resulted in a similar or increased number of INPs, which is contradictory to the results described in this manuscript. The authors should address the discrepancy.

2. Regarding the mitochondria morphology, I am really not sure if anyone could easily see the difference in different groups in Fig 1B, Fig 3A, Fig6C, fig S2A, and FigS5D without looking at the quantification data except that it is clear that expressing Drp1SD leads to aggregation of mitochondria on one side of the NB. They all appear spherical to me. At least I don’t see the clear difference between spherical and elongated/tubular mitochondria structures as shown in some published papers. In fact, mitochondria should mostly appear spherical in normal type I and type II NBs according to published papers rather than tubular as described in this manuscript. The authors may want to confirm their results using different mitochondria markers to verify their findings. Furthermore, the authors should measure the length of the mitochondria for quantifying the mitochondria phenotypes. Also, I am not sure if anyone could count the number of mitochondria accurately with the resolution and quality of the images shown in the manuscript. Personally, I don’t think so and I don’t have confidence in the quantification data of the mitochondrion numbers shown in this manuscript. I don’t think it is extremely important to quantify the number of mitochondria (unless they can truly distinguish individual mitochondria, but that obviously is not the case as they stated that they only quantified the area of “optically resolvable” mitochondria, meaning that at least some mitochondria are not optically resolvable in their images). What matters is the morphology (the area and length) of the mitochondria. If the authors are not totally confident about the quantification data of the mitochondria numbers, these bar graphs should be simply removed.

3. The authors counted wrong cells for quantifying the number of GMCS for Fig 2E, Fig 3G, Fig 7E, Fig S2G, Fig S3F. The authors used Pros staining as a single marker for identifying GMCs. However, Pros is not only expressed in GMCs but also neurons (particularly young neurons). The expression of nuclear Pros in GMCs is usually weaker than that in neurons. The authors counted mostly the cells with strong Pros staining as GMCs, but actually these cells mostly are neurons rather than GMCs. To quantify GMCs, they need to use additional makers such Elav or Ase. GMCs express nuclear Pros and Ase but not Elav or Dpn. In addition, I don’t think their quantification of the number of immature INPs in fig 2C is totally accurate. The number of immature INPs never exceed 10 per lineage in normal brains, but they have several samples that have more than 10 imINPs per lineages. The authors have to make sure not to include cells with weak nuclear Pros staining as imINPs or they could other markers such PntP1 staining to label imINPs. Further, even if the authors use the Pros staining for quantifying the number of neurons, the quantification results may not be reliable either because mCD8-GFP driven by pntP1-GAL4 can not label all cells in type II NB lineages.

4. The authors showed that Marf RNAi knockdown led to a reduction in the number of Pros+ cells in type II NB lineages but did not affect the number of imINPs, mINPs, or pH3+ cells in the lineages. Logically it does not make sense unless that there is an increase in apoptotic cell death of postmitotic neurons, which seems not likely based on what they found with Opa1 knockdown. The authors may want to take a look at apoptosis after knocking down Marf and discuss why there is a reduction in Pros+ cells after knocking down Marf.

5. In Fig 6, the data show that knockdown of Opa1 leads to a reduction in the number of pH3+ cells in type II NB lineages but expressing Drp1SD does not, however, when Opa1 RNAi and Drp1SD are expressed simultaneously, there is an increase in the number of pH3+ cells. Logically it does not make sense. Same concern for the increased number of pH3+ cells resulting from the simultaneous expression of Marf RNAi and Drp1SD. The authors may want to double check their quantification data to make sure they are accurate.

6. I do not find data shown in Fig 6 are particularly informative. The purpose of this figure is to investigate why knocking down of Opa1 or Marf leads to reduction in the number of mINPs and/or Pros+ cells. They need to look at the mitotic rate of individual cells types including type II NBs, mINPs, and GMCs separately rather than just count the total number of pH3+ cells in the lineages, which does not tell whether there is any defect in proliferation of type II NBs, mINPs or GMCs. With the data they have right now, they cannot draw the conclusion that “opa1 depletion decreased the rate of mINP proliferation” (at the end of 1st paragraph on page 11).

7. There is inconsistency between what the authors described and the literature they cited. For example, at the beginning of the second paragraph on page 5, they described that mitochondria are tubular and cited the reference #31. However, in that reference, it is clearly stated that mitochondria in NBs appear spherical, which is also confirmed in other publications such as the reference #24 they cited.

8. In Fig S3 (the 3rd paragraph on page 6), the authors used woriu-GAL4 to knockdown Opa1, Marf, or Drp1 and labeled the brains with Miranda staining for quantifying the number of type I and type II NBs. Miranda is expressed in both type I and type II NBs. Without any additional markers, how could the authors distinguish type I vs type II NBs?

9. For Fig S4A-B, I am not convinced that there is any positive pAMPK staining signal in the NBs. They all appear similar to the background.

10. In Fig 6A-B, the authors quantified the number of mINPs by counting the number of Dpn+ cells. However, expressing NotchFL would lead to dedifferentiation of imINPs and generation of extra type II NBs. They need to include additional Ase staining to ensure they are not counting the dedifferentiated type II NBs after expressing NotchFL.

11. In Fig 6C-E, the authors found that expressing NotchFL led to an increase in the mitochondria area and a reduction in the number of mitochondria. However, when Nintra was express, they found that the area of mitochondria was not affected but the number was reduced. Nintro is supposed to have stronger effect than NotchFL. It has been shown in the reference #24 that knocking down Numb, which will lead to over-activation of Notch signaling like the expression of Nintra, led to fusion of mitochondria and that this phenotype is a common feature of tumorigenic NBs as knockdown of Brat also led to a similar fusion of mitochondria. Therefore, the results are contradictory to published data. It seems unlikely that expressing Nintro would not lead to tubular mitochondrial morphology and an increase in the area of mitochondria.

12. The loss of mINPs in Notch RNAi type II NB lineages is at least in part to due to ectopic Ase expression in type II NBs and subsequent transformation of type II NBs into type I NB. If Drp1SD expression partially rescued the number of mINPs and Pros+ cells in Notch RNAi type II NB lineages as shown in Fig 7, does the Drp1SD expression also suppress the ectopic Ase expression in Notch RNAi type II NBs? If mitochondrial fusion induced by the expression of Drp1SD could not rescue the loss of type II NBs resulting from Notch RNAi, why could it alleviate notch signaling defects in mINPs and rescue the loss of mINPs? Could the author provide any reasonable explanations? Also, in Fig 7D, it seems that Pros staining did not work well for Drp1SD Notch RNAi group. The staining pattern is very different from those in other panels. Dpn staining for NotchFL Marf RNAi in Fig7F did not go well either in Fig7F. It looks like just background. The author should redo the staining of Pros and Dpn for these two groups. Further, co-staining of Ase should be done for Fig7F to unambiguously distinguish type II NBs from mINPs because the expression of NotchFL causes dramatic increase in the number of type II NBs due to dedifferentiation of imINPs and some dedifferentiated NB may still remain small and are difficulty to be distinguished from mINPs based on the cell size.

13. The authors need to describe clearly what they mean by “differentiation of type II NB lineages” when they use this term to describe the phenotypes. This is a very vague term and could mean a lot of things, such as differentiation of NBs, differentiation of INPs, neuronal identity specification, etc. They need to be more specific when describing the phenotypes. They need to make it clear the phenotypes are defects in type II NB proliferation/self-renewal, INP maturation/proliferation/self-renewal, GMC production/division, or neuronal production/fate specification. The authors also should not use the term “mutant” for RNAi knockdown. They are different.

14. The subtitle on page 12 “Mitochondrial fusion induces differentiation on Notch depletion in the type II NB lineage” is very confusing. Did the author mean “Mitochondrial fusion induces differentiation of Notch-depleted type II NB lineages”?

Reviewer #2: Dubal et al., shows in this ms that mitochondria architecture is important for differentiation of type II lineages. They show that Drp1 (fission protein) has a different phenotype to the of Opa1 and Marf (inner membrane fusion protein and out membrane protein) respectively. The latter two shows loss of mitochondria activity and failure for type II NBs to differentiate (just like notch mutant). OPa1 is also required for MMP and caused increased cytochrome c in type II NBs when inhibited. Opa1 depletion decreased the rate of mINP proliferation in the type II NB via decreasing its rate of cell cycle progression. Finally, the authors show that inhibiting Notch RNAi causes failure to differentiate, and this can be rescued by Drp1 dominant negative. The work is of general interests to the field of developmental neurobiology, as it shows that fission and fusion of the mitochondria is important for NB differentiation.

Major points:

I see two main issues with this ms. First is the quantification of mitochondria fusion/fission phenotype, the images are not very obvious to interpret, and how quantification can reflect these phenotypes is not so clear. Either representative 3D reconstruction should be provided, or clearer explanation of how quantification is done should be provided.

The second issue is regarding the discrepancy of Notch activated vs Notch RNAi phenotype, and why Notch intra/Full length is rescued by Opa1 and Marf in terms of NB number, and conversely why Drp1 DN rescues the differentiation phenotype (which makes a lot more sense than the former).

1. “Opa1, Marf and Drp1 depletion by multiple RNAi lines and mutants showed survival of animals until the pupal stage with inscuteableGal4 and worniu-Gal4 and were lethal or showed behavioral defects as adults.”MarfRNAi seems to be published else where, is Opa1 and Drp1 RNAis validated? Should be done with qPCR.

2. It is not clear to me how mitochondria number is estimated in Fig 1B and S2, as the mitochondria punctas are not well separated. In the methods, it is stated that watershed tool is used, however, does this work, if all objects are touching? Additional more convincing images are needed to support this data.

3. What are the weakly positive pros cells in Figure 2 S2 and Figure 3? How do you make conclusions that it is GMCs and not INPs, if Dpn is not used in conjunction in the same sample?

4. Notch RNAi causes mitochondria fragmentation and by suppressing Drp1, then differentiation (not nb number) is rescued significantly. To better quantify the differentiation phenotype, overall clone volume of type II lineages under the genetic manipulations should be estimated.

5. TMRM intensities were computed in the entire type II NB in control, opa1 RNAi and marf RNAi expressing brains and in the clustered mitochondria in Drp1SD, Drp1SD;opa1 RNAi and Drp1SD;marf RNAi expressing brains using ImageJ. Why different parameters?

6. Notch intra full length gives ectopic NBs, and Opa1 and Marf1 RNAi surpresses the fusion, and somehow affects NB number. How this happens is not clear to me. The authors suggests it is via affecting NB proliferation, but it could also be due to affecting the rate of INP to NB dedifferentiation, the authors should show which is the case.

Minor points:

S3 was cited before S2 D,E, citing of S figures are all over the place.

“Our data together shows that mitochondrial morphology is tubular in type II NBs and fusion of mitochondria alone did not give a differentiation defect but was able to suppress the differentiation defect in opa1 mutant NBs”. This is a long sentence, perhaps needs rewriting.

Reviewer #3: In this manuscript, Dubal et al investigated the role of mitochondrial morphology during differentiation of type II neuroblasts in Drosophila. The authors performed genetic and imaging experiments to assess the effect of blocking mitochondrial fusion or fission on neuroblast proliferation, differentiation and viability. They found that depletion of Opa1 results in changes in mitochondrial network and reduced neuroblast differentiation. The authors further showed the differentiation defect induced by knocking down Opa1 is not due to cell death, but more likely the consequence of a reduced proliferation rate of neuroblast. Finally, the authors investigated how Notch signaling intersects with mitochondrial morphology in regulating neuroblast differentiation. Although many findings including those showing the effect of knocking down fusion & fission proteins on the morphology of mitochondria are not novel as they have been shown extensively by others, some data could be a worthwhile contribution to the field of stem cell mitochondrial dynamics. Nevertheless, there are a number of conclusions that require additional support and controls to be rectified.

Major comments

1. The authors claimed that the phenotypic effects of Opa1-RNAi can be rescued by combining opa1 depletion with the overexpression of a Drp1 dominant negative construct (Drp1sd), which is presumably UAS-Gal4 based (the authors need to specify the nature of the construct in the manuscript somewhere, see below). Theoretically, Drp1sd should promote fusion to counteract Opa1 RNAi induced fission. They also use a similar approach for other RNAi lines (e.g. Marf1 RNAi and notch RNAi) and also combine NotchFL with Opa1 or marf1 RNAi. However, the authors compare these combined genotypes to Drp1SD (or NotchFL) alone, when the correct control would be in combination with another RNAi that has no phenotypic effect (e.g. mCherry RNAi). This is because an increased number of UAS-driven constructs within a genotype can reduce their overall expression by limiting available Gal4. Many of the effects they see when comparing combined genotypes to single genotypes could be explained by such a dosage effect. Therefore, a correct control must be included to draw conclusion based on these experiments. What’s more, because Drp1sd is a novel line, the manuscript would benefit from further details about this line in the methods section, such as the vector used to clone the Drp1sd (e.g. UASt or UASp), into which chromosome this construct was inserted? I also wonder why Drp1sd overexpression is used in combination with Opa1/Marf RNAi instead of combining DRP1 RNAi and Opa1/Marf RNAi to achieve double knockdown. Based on Table S1, Drp1 RNAi seems to work well as it gave a similar defect at the organismal level.

2. Despite that the authors used the STED super-resolution imaging to visualize the mitochondrial network in neuroblasts and differentiated cells, the quality of the images is not impressive. It is hard to tell whether those mitochondria in Drp1sd overexpressing cells or notch down-regulating are fused, or simply it is an aggregation of many small mitochondria (e.g. Fig 1B, Figure 3A & Figure 6 etc). A number of images were over-exposed with over-saturated signals, and this will affect the qualifications presented in those figures.

3. Given that Opa1 and Marf knockdown gave a different level of differentiation deficiency, and Opa1 has the additional role in cristae remodelling (which is directly linked to electron chain transport capacity) besides being a mitochondrial fusogen like Marf, it will be great to show the cristae structure by electron microscope after Marf and Opa1 knockdown. However, I understand that performing such additional experiments could be challenging during the pandemic.

4. Page 13, 2nd paragraph, the authors state: In summary our results show that mitochondrial fusion controlled by Opa1 and Marf regulate Notch signaling driven differentiation in the Drosophila. I feel the rescue data in Fig 7 are not sufficient to support such a statement. Does Opa1 and Marf knockdown reduce notch signaling? Does notch knockdown lead to decreased Opa1 and Marf expression? In the discussion, the authors stated: our preliminary analysis shows that Opa1 mutant type II NBs show a loss of notch receptors on the plasma membrane and increase in endosomes in the type II NB and the lineage (data not shown). It is an important piece of data to support the link between notch and mitochondrial fusion proteins. Why these data are not shown to further support the statement made in the last paragraph of the discussion, which is “we find a distinct role for mitochondrial fusion in regulation of notch signaling in type II NB differentiation”.

5. At multiple points in the manuscript, the authors used the term “mutants” to refer to RNAi lines or Drp1sd overexpression, which is not correct. Please use a more accurate phrase such as “Opa1 or Marf depleted genotypes” or “combined genotypes”, as relevant.

Minor comments

1. Some of the panels in supplementary figures could be moved into different figures to aid the flow. Specifically, S2D-G would be better suited in S3 and S4E-G would be better suited as a separate figure.

2. Page 5, 1st paragraph, “multiple RNAi lines and mutants” should be replaced by “multiple RNAi lines and overexpression of a dominant-negative Drp1 mutation”.

3. Page 7, 3rd paragraph, which Gal4 did the authors use to drive the expression of RNAi and Drp1sd overexpression? Please specify.

4. Page 11, 1st paragraph, “also showed significant increase in PH3” should be replaced by “also showed a significant increase in PH3”.

5. In the first paragraph of the section “Mitochondrial fusion induces differentiation on Notch depletion in the type II NB lineage”, please briefly describe relevance of Nintra whilst introducing Notch signaling.

6. Page 11, 2nd paragraph, do the authors intended to say “Notch signaling is activated in type II NBs and suppressed in immature INPs.”?

7. Figure 1B – These images would benefit from also showing nuclear staining if the authors already have already done so, because the high background of CD8-GFP makes delineation of the neuroblast difficult to distinguish.

8. Figure 1C - A limitation of this quantification of mitochondrial area and number is that these measurements were done on a single plane. As it is difficult to overcome this limitation, it would be useful to have this clarified in the figure legend.

9. The final paragraph of the section “Mitochondrial fusion is required for differentiation in the type II NB lineage” would be more suitable for the discussion, so should be moved or shortened.

10. Figure 3D – The same control images has been used for Figure 2 and 3. It therefore may be more appropriate to group Figures 2 and 3 rather than repeat data.

11. Figure 4A – What the numbers on the panels represent has not been stated or, if stated, should be made clear.

12. Figure 4B and associated text - Please expand on how neighboring cells were selected and identified for comparison (also for S4B and S4D).

13. Figure 7G – There is inconsistency to other figures because the NB number has not been normalized per hemisphere. Is there a reason for this?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: No: 

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Gregory P Copenhaver, Hongyan Wang

20 Jul 2021

Dear Dr Rikhy,

Thank you very much for submitting your Research Article entitled 'Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. While reviewers agreed that the revision was improved, they shared similar concern that the quantification of the individual mitochondrion and labeling of distinct cell types within neuroblast lineages were not convincing. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Hongyan Wang, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The manuscript has improved to some extent and authors have address some of my concerns. However, some critical concerns I had before still have not been addressed. Some of their conclusions are still not well supported by their data and some data could be even mis-leading. Given that there are still so many concerns/problems after revision, I would not support publication of the manuscript in PLoS Genetics.

Here are some of the major concerns that still remain to be addressed (most of these concerns are the ones I mentioned previously).

1. The authors showed that Opa1 knockdown led to a reduction in the number of Dpn+ cells, Ase+ cells, and Pros [high] cells. By co-staining of pH3, they further showed that mitotic rate of mINPs (Dpn+ cells) was reduced. Based on these data, the author concluded that the reduction of Dpn+ cells was because of the reduced mitotic rate of mINPs. However, if mINPs have a reduced mitotic rate, there should be an increase in the number of mINPs (as they argued that reduction in the mitotic rate likely accounts for the increased number of GMCs in Marf knockdown lineages) unless the number of cell cycles that mINPs will undergo is reduced and mINPs terminate their self-renewal prematurely. They have to look at the mitotic rate of type II NBs upon knockdown of Opa1 (and Marf knockdown as well) as I suggested previously. Reduction in the mitotic rate of type II NBs certainly will also lead to a reduction in the number of mINPs and more likely is the real reason.

2. The authors showed that Marf knockdown resulted in an increased mitotic rate of Dpn+ cells (mINPs), an increased number of Ase+ cells, and a reduction in the number of Pros[high] cells, without changes in the number of mINPs. They concluded that the number of GMCs was increased but GMCs failed to produce neurons or produced much fewer neurons. They offered two different explanations for the increase in the number of GMCs and reduction in the number of Pros[high] cells: increased proliferation of mINPs and reduced proliferation of GMCs in the results and discussion parts. There are many problems here. First, if mINPs divide more quickly than usual, then the number of Dpn+ mINPs should be reduced unless mINPs can undergo more cell cycles than wild type mINPs. They should provide data to show if the number of cells cycles of mINPs is changed or not (e.g. by examining the number of neurons generated in an INP clone). Second, if they think that the number of GMCs was increased after Marf knockdown, they need to do Ase and Pros co-staining rather than Ase staining alone to un-ambiguously identify GMCs for quantifying the number of GMCs. Third, they need to examine the mitotic rate of GMCs specifically by co-staining Ase, Pros, and pH3, if they suspect that GMCs do not divide as actively as usual after knockdown of Marf. It seems odd that knockdown of Marf would increase the proliferation of mINPs but decrease the proliferation of GMCs. How could knockdown of Marf have totally different effects in INPs and GMCs in terms of cell proliferation?

3. Quantifying the number of neurons in type II NB lineages by counting the number of Pros[high] cells in type II NB lineages labelled with mCD8-GFP driven by pnt-GAL4 is not a proper way for quantifying the number of neurons and the results could be misleading. The reason is because pnt-Gal4 is only active in type II NBs and imINPs and mCD8-GFP expression in the progeny decreases gradually and dose not label all the cells produced in individual type II NB lineages. The expression of mCD8-GFP driven by pnt-GAL4 does not tell where is the boundary of the lineage. They have to label the lineages with mCD8-GFP driven by either elav-GAL4 or tub-GAL4 and compare the number of neurons in MARCM clones or flipout clones.

4. Throughout the entire paper, the mitochondria morphology is examined in type II NBs, however, the proliferation/differentiation defects were mostly observed in INPs/GMCS/neurons. Are the defects in mitochondrial morphology observed in type II NBs resulting from Opa1/Marf/Drp1 knockdown/inhibition or Notch manipulations really responsible for the proliferation/differentiation defects of INPs/GMCs? Or actually do these manipulations cause similar mitochondrial morphological defects in INPs/GMCs, which in turn impact their proliferation/differentiation? The authors should examine the behavior of type II NBs and mitochondrial morphology in INPs/GMCS after Opa1/Marf/Drp1 knockdown/inhibition or Notch knockdown/overexpression.

5. In terms of mitochondrial morphological defects described in the manuscript, only thing obvious and convincing to me is that expressing Drp1SD leads to aggression of mitochondria. I am not sure if anyone can see the mitochondrial morphological defects described for Opt1/Marf/Notch or overexpressing NotchFL/Nintra without looking at the quantification data. Furthermore, in Drp1SD expressing NBs, mitochondria all aggregate together, how could they measure the area of individual mitochondria. If they measured the region where they could see individual mitochondria as they mentioned, then obviously the data are not representative and does not truly reflect the phenotype observed in Drp1SD expressing NBs.

6. As I mentioned previously, the data presented in this manuscript are not consistent with a published paper (Bonnay F, et al, Cell 2020, 182, 1490) in terms of the number of mINPs in Marf and Opa1 knockdown type II NB lineages. The authors should test the same VDRC RNAi lines used by Bonnay F et all to see if they can reproduce the results. They should also discuss the discrepancy of the results in the discussion part.

7. The authors suggest that Notch signaling regulates mitochondrial fission/fusion by activating the expression of Opa1, which in turn regulates Notch signaling by promoting translocation of NICD from the cytoplasm to the nucleus. So there is a positive feedback loop of Notch signaling and Opa1. However, I don’t find that their data are convincing enough to support that Opa1 regulates Notch signaling by regulating the nuclear import of NICD. The biggest concern I have is that E(Spl)-GFP [by the way, it should read E(Spl)m�-GFP as there are multiple different E(Spl) genes] signal is reduced in type II NBs when prospoero-GAL4 drives the expression of UAS-opa1 RNAi (Fig6E-G). Prospero-GAL4 is not expressed in type II NBs at all. It is only expressed in INPs and GMCs. Therefore, Opa1 is not knocked down in type II NBs at all when UAS-opa1 RNAi is driven by prospero-GAL4. How could E(Spl)m� -GFP expression in type II NBs be affected in this case? By the way, comparing the E(Spl)m�-GFP expression levels by comparing the signal/noise ratio certainly is not the best way for quantifying the E(Spl)m�-GFP expression. Furthermore, I am not totally convinced that NICD staining could be used to assess the activation of Notch receptors in this case. The NICD antibody recognize both the uncleaved Notch as well as cleaved NICD. And I do not see clear NICD signal in the nucleus. In fact, in their discussion part, the authors state that “our observations show that Opa1 depleted type II NBs show a loss of Notch receptors on the plasma membrane and increase in endosomes in the type II NB and in the cells of the lineage”, which is not shown in their figures at all. In Fig 6C-D, they only compared the ratio of cyto/nuclear of NICD staining intensity. Therefore, more convincing data are needed to further support that Opa1 regulates Notch signaling. It is hard to imagine that mitochondria proteins like Opa1 would regulates the translocation of NICD from the cytoplasm to the nucleus. The authors did not provide any reasonable explanation either in the discussion part. If they cannot provide more convincing data, the model proposed in Fig 8 should also be modified.

8. In lines 375-277, the authored stated that “We also observed a change in the mitochondrial morphology …… (Figures S8A-B)”. However, in that figure, they only show the stainining of Dpn and Ase and wild type and NotchFL overexpressing lineages. Also, in this figure, I would expect to see ectopic type II Nbs in NotchFL overexpressing lineages, but the lineages shown in the figure look pretty normal and did not have any extra type II NB lineages. Why?

9. In my previous comments (#12), I suggested to examine the expression of Ase in in Drp1SD Notch RNAi type II NBs to further elucidate how Drp1SD expression could rescue the loss of mINPs in Notch RNAi lineages. However, they still did not do it. In response to my comment, they stated that “2. Ase is not present in the type II neuroblast lineages at the third instar larval stage in Drp1SD; notch RNAi” and cited again Figure S8. However, Fig S8 is about NotchFL overexpression, not notch RNAi. So they cited the same figure wrongly at least twice (see above #8). They also argued that “3. We have Dpn and Ase antibodies in the same animal and hense we could not check for loss of conversion of type I by dissecting brains at earlier time points”. This does not sound a reasonable excuse for not examining the Ase expression in Drp1SD, notch RNAi type II NBs. First, the check the expression of Ase in Drp1SD, notch RNAi type II NBs, it does not require co-staining of Dpn and Ase. Ase staining alone is sufficient. mCD8-GFP driven by pnt-GAL4 would allow for identification of type II NBs. Second, the ectopic Ase expression (thus the conversion of type II NBs into type I NBs can be observed in late larval stages when Notch is knocked down according to published papers.

10. Related with the rescue of Notch RNAi phenotypes by Drp1SD, the authors showed that Drp1SD could rescued the number of mINPs and Ase+ cells but not Pros[high] cells. That does not seem to make sense. The authors should explain how this could happen.

Other minor concerns:

11. In lines 419 – 421, they stated that “the loss of Dpn positive cells in notch RNAi… was suppressed completely … (Fig 7A, E)”, but the bar graph in Fig7E still show statistically significant difference between +/+ and Drp1SD; notch RNAi. So the suppression is not complete. The statement should be modified.

12. In lines 542 – 545, the authors stated that “Drp1 mutant …. that Drp1 is dispensable for NB formation….”. It is an overstatement because the expression of Drp1SD is driven by pnt-GAL4, which is only expressed after type II NBs are formed. Therefore, they cannot conclude that Dpr1 is dispensable for NB formation.

13. Line 627: dilution of the Ase antibody should be indicated.

14. For estimating the number of Ase+ neurons, they used the average area of Pros+ nuclei of 5 GMCs (lines 759-765). However, the size of GMCs may not necessary be the same as neurons. They should use the average area of Pros+ nuclei of neurons instead of GMCs.

15. In fig6C opa1 RNAi, what do the yellow arrows point to? It is not mentioned in the figure legends.

16. Fig 7E, Y-axis, Dpn+ve should be changed to Dpn+

Reviewer #2: The authors have addressed some of my concerns from the previous version of the ms, and in general, the data quality has improved. I however still have several reservations.

I have still a problem with the data shown in Figure 1, the authors claim that there is fragmentation of mitochondria, and indeed in the particular ROI they have chosen, the quantification is reflective of their observation. However, it is not clear to me how this box is chosen in the top three panels of Figure 1B. To make this point more convincing, the authors should choose multiple ROIs in the same section and perform the analysis, as a minimum. Similar point applies to Figure 3A, the claim that the phenotype is to do with fragmentation of the mitochondria is still not very convincing. In Figure 3, seems like the more striking and perhaps easier to quantify phenotype is the aggregation of the mitochondria to one side of the neuroblast, and maybe the total amount of mitochondria is increased in Drp1SD and similarly in combination with opaRNAi and MarfRNAi. Is there an explanation as to why the fusion causes aggregation of the mitochondria to one side of the NB?

In Figure 2H, as the authors are unable to show Dpn and Ase together due to technical reasons, it is a claim too far to say that it is definitely mature INP to GMC transition that is impacted in MarfRNAi. Furthermore, in the summary diagram, if Dpn/Ase double positive cells could not be ascertained, I don’t see how it can be summarised as such in the diagram.

Reviewer #3: The authors have put in a commendable effort to improve the manuscript. They have considered many of the reviewer’s comments and implemented most in some way. In particular, changes to the manuscript writing, figure legends and explanations of methodology and stocks has improved understanding of their presented results. The additional results obtained showing reduced Notch signaling upon Opa1 knockdown are very interesting and provides additional evidence for a link between Notch signaling and mitochondrial morphology in differentiation that will be exciting to follow up.

However, the authors have still failed to convince me about the way that they quantify mitochondrial morphology and distinguish NB lineages/cells. The mitochondrial images presented in Figure 1B are clearer in the revised manuscript, but I doubt whether they are sufficient to allow accurate quantifications of mitochondrial morphology. On top of that, the quantifications were performed on regions manually chosen for those where mitochondria are most distinct, which does not necessary reflect the overall morphology in a given cell. I empathize with the authors as mitochondrial morphology quantification is challenging, but this is a very important part of the manuscript and the current data raise more doubts than adding any strength to the author’s conclusions. Similarly, it is not entirely convincing that the authors were able to distinguish different neuroblast lineages as nearly all quantifications in Figure 2 rely on a single marker, except for Figure 2D for which representative images are unfortunately omitted. This deficiency, plus my concern in the mitochondrial quantification method, makes it hard to judge the reliability of the overall conclusion of the paper. I, therefore, cannot recommend this paper for publication at this stage.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 2

Gregory P Copenhaver, Hongyan Wang

12 Jan 2022

Dear Dr Rikhy,

Thank you very much for submitting your Research Article entitled 'Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript. While we appreciate Reviewer #3’s concern that image quality needs to support the underlying analysis and conclusions, the editors and the other two reviewers are satisfied, so we will not require additional experimentation to acquire new images (though you are welcome to include improved images in the revision if you are able). Please respond to the remaining concerns in your revision.<o:p></o:p>

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Hongyan Wang, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I appreciate that the authors put a tremendous amount of effort into the revision. The manuscript has been improved significantly and most of my concerns have been addressed. Although I still have some reservation about the quantification of the area of mitochondria, the additional quantification of clustered/dispersed/fragmented mitochondria is helpful to some extent. I only have two suggestions.

First, If the authors insist on quantifying the number of neurons by labeling the type II NB lineages with mCD8-GFP driven by pntP1-GAL4 and Pros staining, they should state clearly that they are quantifying only young neurons, not the total number of neurons. Strong Pros expression is only in young/newly-born neurons, not in old neurons. Furthermore, the expression mCD8-GFP driven by pntP1-GAL4 certainly does not label all the cells in type II NB lineages (as they also stated in the response letter that sometimes they could not determine the boundary of the lineage based on the mCD8-GFP expression).

Second, I would suggest to provide bar graphs for the quantification of clustered/dispersed/fragmented mitochondria in the figures (1, 3, 6, S10) instead of providing the numerical data in the figure legends. Also, they should clearly describe these quantification data in the text of the Results part.

Reviewer #2: The revisions were done to my satisfaction.

Reviewer #3: Although the morphological changes of the mitochondrial network are better described in the revised version, the poor quality of microscope images in multiple figures still failed to convince us that they are sufficient to allow reliable quantifications of mitochondrial morphology. We, therefore, would like to keep our decision from the previous round of revision.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 3

Gregory P Copenhaver, Hongyan Wang

27 Jan 2022

Dear Dr Rikhy,

We are pleased to inform you that your manuscript entitled "Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Please note that Reviewer #1 (see below) has indicated that an issue with the scale bar in several figures needs attention.  Please address this as you prepare your final draft for the production team (the editorial team will not need to re-evaluate).

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Hongyan Wang, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have adequately addressed my concerns.

Only one minor thing about scale bars. They need to state clearly which scale bar represents 5um and which one 2.7um in the figure legends for Fig 1 and Fig 3. What scale bars represent in Figs S5, S6, S7 S8, and S9 should also be stated in their figure legends.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-01908R3

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Hongyan Wang

8 Feb 2022

PGENETICS-D-20-01908R3

Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila

Dear Dr Rikhy,

We are pleased to inform you that your manuscript entitled "Mitochondrial fusion regulates proliferation and differentiation in the type II neuroblast lineage in Drosophila" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Table showing analysis of mitochondrial morphology protein knockdown with different neuronal Gal4s.

    Various Gal4 drivers were crossed with RNAi depletion lines and a Drp1 dominant negative mutant of mitochondrial morphology genes at 25 or 29°C and lethality or behavioral phenotype was recorded in the adult. worniu-Gal4 (wor-Gal4), inscuteable-Gal4, prospero-Gal4 and scabrous-Gal4 expresses the Gal4 in all NBs, pnt-Gal4 expresses in type II NBs and elav-Gal4 expresses in neurons. Adult flies from crosses with wor-Gal4 (25°C) and pnt-Gal4 (29°C) with opa1 RNAi and marf RNAi were sluggish and the numbers obtained were at the expected frequency, no lethality was seen at the pupal stage. elav-Gal4 crosses gave lethality and few adults emerged. The opa1 RNAi BL32358 and opa1 RNAi2 BL67158 gave stronger phenotypes as compared to opa1 RNAi Ming Guo lab with inscuteable-Gal4, prospero-Gal4, elav-Gal4 and scabrous-Gal4. The marf RNAi Ming Guo lab and marf RNAi2 BL67159 gave stronger phenotypes as compared to marf RNAi BL31157 with inscuteable-gal4, prospero-Gal4 and elav-Gal4. We chose opa1 RNAi BL32358, opa1 RNAi2 BL67158, marf RNAi Ming Guo lab and marf RNAi BL67159 for further analysis. The Drp1 RNAi from VDRC did not show phenotypes and the Drp1 (BL51483) gave inconsistent results, hence we used a lab generated construct overexpressing the GTPase domain mutant Drp1SD for further analysis.

    (TIF)

    S2 Fig. Depletion of mitochondrial fusion proteins Opa1 and Marf result in mitochondrial fragmentation.

    A, B:Mitochondrial morphology and distribution in type II NBs (white dotted line, magnified area shown in the panel on the right) stained with ATPβ (red) antibody using STED super resolution microscopy is shown in representative images with zoomed inset in the right panel (A). Control (100% tubular, 75 NBs, 22 brains), opa1 RNAi2 (100% fragmented, 14,4), marf RNAi2 (100% fragmented, 14,4). Average mitochondrial area quantification from type II NBs (B) in control (10 type II NBs, 4 brains), opa1 RNAi2 (8,4), marf RNAi2 (5,3). Scale bar- 5μm. C: Clonal analysis of NB clones (green) expressing drp1KG allele show clustered mitochondria stained with ATPβ antibody (red). FRT40A drp1KG (8 NB clones), FRT40A;opa1 RNAi (13), FRT40A drp1KG;opa1 RNAi (13). D: Representative confocal images of mitochondria labeled with mito-GFP (green) in larval muscles. Expression of opa1 and marf RNAi by mhc-Gal4 shows smaller mitochondria while Drp1SD shows large mitochondria compared to control. Representative images from a minimum of 3 larvae are shown, the phenotype of smaller mitochondria is at 100% in muscle 6 and 7 of segment A2 and A3 in opa1 and marf RNAi and of larger mitochondria in Drp1SD overexpression. Scale bar-3μm.

    (TIF)

    S3 Fig. Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage.

    A,C:Type II NB lineages (yellow dotted line) showing expression of mCD8-GFP (green) and Dpn (red, yellow arrows) (A). Quantification of Dpn positive mature INPs (C) in control (20 NB lineages, 5 brains), opa1 RNAi2 (19,4), marf RNAi2 (15,4). Scale bar- 10μm. B: Quantification of number of type II NBs in control, opa1 RNAi, marf RNAi, Drp1SD (n = 15 brains each). C,E:Type II lineages (pnt-Gal4, mCD8-GFP, green) showing Pros positive INPs (red, yellow arrows) (C, yellow arrows). Quantification of Pros positive young neurons (E) in control (28 NB lineages,8 brains), opa1 RNAi2 (19,4), marf RNAi2 (18,4). Scale bar- 10μm. F-G: Representative type II NB lineages showing reduced numbers of mature INPs and GMCs in opa1 RNAi from VDRC stock center. Quantification of mature INPs (G) in mCherry RNAi, opa1 RNAi (VDRC), marf RNAi (VDRC). Analysis of numbers of GMCs (Dpn- Ase+, yellow arrows) in type II NB lineage in mCherry RNAi (19 type II NB lineages, 6 Brains), opa1 RNAi (VDRC) (20,5), marf RNAi (VDRC) (12,5). B,D,E& G: Graphs show mean ± sd. Statistical analysis is done using an unpaired t-test. ns- non significant, ***- p<0.001.

    (TIF)

    S4 Fig. NB polarity and number are unaffected by knockdown of mitochondrial morphology proteins.

    A, B: Representative confocal images of larval brain lobes stained for Miranda (red) show no change in NB number (A). Expression of opa1 RNAi, marf RNAi and Drp1SD was done by wor-Gal4. Quantification of NB number in larval brain lobes (B) of control (13 lobes,13 brains), opa1 RNAi (10,10), marf RNAi (10,10), Drp1SD (10,10). Scale bar- 50μm. C: Representative images showing apical Bazooka and basal Numb localization in control and mitochondrial dynamics mutants. Bazooka is present at the apical side (away from progenies) and Numb at the basal side (near the progenies) in dividing NBs of all genotypes. Scale bar- 10μm. D, E: Representative images of brain lobes showing reduced Pros positive cells in opa1 RNAi expressed with wor-Gal4, mCD8-GFP (D). Analysis of bright Pros positive cells (E) in control (10 lobes,10 brains), opa1 RNAi (11,11), marf RNAi (7,7), Drp1SD (11,11). Scale bar- 50μm. B, E: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant, ***- p<0.001.

    (TIF)

    S5 Fig. Expression of mRFP does not perturb the severity of opa1 RNAi and marf RNAi phenotypes.

    A, D: Representative confocal images of type II NB lineages showing expression of Dpn (grey scale) (A) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of Dpn positive cells (yellow arrows) (D) in opa1 RNAi (21 Type II NB lineages, 6 Brains), mRFP;opa1 RNAi (25,4), marf RNAi (15,8), mRFP;marf RNAi (15,3). Scale bar- 10μm. B, E: Representative confocal images of type II NB lineages showing Ase positive cells (grey scale) (B) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of Ase positive cells (yellow arrows) (E) in opa1 RNAi (12 Type II NB lineages, 5 Brains), mRFP;opa1 RNAi (16,3), marf RNAi (10,4), mRFP;marf RNAi (15,3). Scale bar- 10μm. C, F: Representative confocal images of type II NB lineages showing high levels of Pros expressing young neurons (grey scale) (C) in opa1 RNAi, mRFP;opa1 RNAi, marf RNAi, mRFP;marf RNAi. Quantification of brightly stained Pros positive young neurons (yellow arrows) (F) in opa1 RNAi (18 Type II NB lineages, 5 Brains), mRFP;opa1 RNAi (15,3), marf RNAi (15,5), mRFP;marf RNAi (13,3). Scale bar- 10μm. D-F: Graphs show mean ± sd. Statistical analysis was done by using unpaired t-test. ns- non significant. Values for opa1 RNAi and marf RNAi are repeated from Fig 2 for comparison.

    (TIF)

    S6 Fig. Depletion of Opa1 does not increase pAMPK in type II NBs.

    A, B: Representative images of type II NBs expressing opa1 and marf RNAi along with pnt-Gal4, mCD8-GFP did not show change in levels of pAMPK (pAMPK fluorescence is shown as a grey scale) (A). Brains of different genotypes were treated with 2-DG and were imaged for pAMPK fluorescence at the same time under the same imaging conditions. Type II NBs are marked by white dotted lines while lineages are marked by expression of mCD8-GFP (green). Analysis of pAMPK intensity normalised with neighboring control cells (B). +/+ (32 NBs,14 brains), opa1 RNAi (23,8), marf RNAi (33,8), DMSO (76,8), 2-DG (91,9). Scale bar- 10μm.

    (TIF)

    S7 Fig. Depletion of Opa1 shows increased ROS levels in the type II NB lineage.

    A, B: Representative images showing increased levels of ROS (rainbow scale) in type II NB (position marked by white dotted line) using pnt-Gal4, mCD8-GFP with different genotypes (A). Analysis of relative DHE fluorescence as a ratio to neighboring cells (B) in type II NBs, +/+ (22 NBs,6 Brains), opa1 RNAi (17,8), marf RNAi (17,8), Drp1SD (9,5), hSOD1 mutant overexpression (13,3). Scale bar- 10μm.

    (TIF)

    S8 Fig. Depletion of Opa1 and Marf does not cause increase in the cleaved Caspase 3 levels and apoptosis in the brain.

    A: Representative images of type II NB lineages (green) stained for cleaved caspase 3 and shown in heatmap. +/+ (for opa1 RNAi, 10 NB lineages, 6 brains), opa1 RNAi (9,6), Control (for marf RNAi, 24 Type II NB lineages, 6 Brains), marf RNAi (30,5). Scale bar- 10μm. B, C: Fluorescence confocal images of brain hemispheres showing no significant change in TUNEL positive nuclei (red, white arrows) (B) in opa1 RNAi expressed in all NBs with wor-Gal4. Scale bar- 50μm. Expression of hid shows a significant increase in TUNEL positive cells when expressed with pnt-Gal4, mCD8-GFP in the type II NB lineage. Quantification of TUNEL positive nuclei (C) in wor-Gal4/+ (3 brains), wor-Gal4 opa1 RNAi (4), pnt-Gal4 UAS-hid reaper (5). Statistical analysis was performed using unpaired t-test. ns- non significant, ***- p<0.0001.

    (TIF)

    S9 Fig. Analysis of proliferation in NBs depleted of Opa1 and Marf.

    A-B: Representative confocal images of larval brain lobes showing reduction of pH3 positive NBs upon loss of Opa1 (A). Analysis of numbers of pH3 positive NBs (yellow arrows) in larval brain lobe in control (8 brain lobes), opa1 RNAi (9), marf RNAi (6). Scale bar- 50μm. C: Quantification of total number of pH3 positive cells, and percentage of dividing mature INPs in type II NB lineages in mCherry RNAi (33 Type II NB lineages,7 brains), Drp1SD;mCherry RNAi (24,6), opa1 (33,6, Drp1SD;opa1 RNAi (26,8), marf RNAi (33,8), Drp1SD;marf RNAi (15,5). D: Representative images of type II NB lineages labeled with CD8-GFP (green), Pros (blue), Ase (red), pH3 (grey) showing reduced mitotic GMCs (yellow arrows, pH3+light Pros+Ase+) in marf RNAi (in support of graph presented in Fig 5D). Scale bar- 10μm.

    (TIF)

    S10 Fig. Notch signaling regulates fused mitochondrial morphology in INPs and muscle cells.

    A: Representative confocal images of type II NB lineage (yellow dotted line) showing expression of mCD8-GFP (green) and Dpn (red) in the NBs. Note that Dpn is present in the NB and in the mature INPs in the lineage +/+ (39 Type II NBs, 5 brains), NotchFL (>100, 5). B: Representative confocal images of type II NB lineage (yellow dotted line) showing expression of mCD8-GFP (green) and Ase (red) in the type II NB lineage. Note that Ase is not present in the NB but present in the lineage +/+ (31 Type II NBs, 5 brains), NotchFL (>100, 5). C-D: Larval brain lobes show suppression of Notch mediated NB hyper proliferation on depletion of Opa1 and Marf (C). Quantification of NB number (D) in pnt-Gal4, UAS-mCD8-GFP control (14 lobes), NotchFL (11), NotchFL;opa1 RNAi (9), NotchFL;marf RNAi (9). Scale bar- 50μm. E-F: Confocal images showing mitochondria (red, stained with ATPβ) in mature INPs of type II NBs expressing mCherry RNAi (40 mature INPs, 5 brains, 8 lineages, 75% intermediate), notch RNAi (49 mature INPs, 4 brains, 10 lineages, 69% fragmented), su(H) RNAi (11 mature INPs, 3 brains, 4 lineages, 81% fragmented) and NFL (68 mature INPs, 4 brains, 13 lineages, 69% clustered). The control cohort is the same as that used in Fig 1. Graph shows the distribution of mitochondria into fragmented, intermediate and clustered in the form of a stacked histogram (F). The percentage documented on each bar in the histogram is for the group that is seen at the maximum extent. Scale bar- 2.7μm. G: Representative confocal images of mitochondria labeled with mito-GFP in muscle cells showing smaller mitochondria in notch and su(H) RNAi and larger mitochondria on Nintra overexpression. The image for control mCherry RNAi is repeated from S2 Fig for comparison. Representative images from a minimum of 3 larvae are shown, the phenotype of smaller mitochondria is at 100% in muscle 6 and 7 of segment A2 and A3 in notch and su(H) RNAi and of larger mitochondria in Nintra overexpression. Scale bar-3μm.

    (TIF)

    S1 Data. File containing data underlying the plots in the Fig 1.

    (XLSX)

    S2 Data. File containing data underlying the plots in the Fig 2.

    (XLSX)

    S3 Data. File containing data underlying the plots in the Fig 3.

    (XLSX)

    S4 Data. File containing data underlying the plots in the Fig 4.

    (XLSX)

    S5 Data. File containing data underlying the plots in the Fig 5.

    (XLSX)

    S6 Data. File containing data underlying the plots in the Fig 6.

    (XLSX)

    S7 Data. File containing data underlying the plots in the Fig 7.

    (XLSX)

    S8 Data. File containing data underlying the plots in the S2 Fig.

    (XLSX)

    S9 Data. File containing data underlying the plots in the S3 Fig.

    (XLSX)

    S10 Data. File containing data underlying the plots in the S4 Fig.

    (XLSX)

    S11 Data. File containing data underlying the plots in the S5 Fig.

    (XLSX)

    S12 Data. File containing data underlying the plots in the S6 Fig.

    (XLSX)

    S13 Data. File containing data underlying the plots in the S7 Fig.

    (XLSX)

    S14 Data. File containing data underlying the plots in the S8 Fig.

    (XLSX)

    S15 Data. File containing data underlying the plots in the S9 Fig.

    (XLSX)

    S16 Data. File containing data underlying the plots in the S10 Fig.

    (XLSX)

    Attachment

    Submitted filename: PLOS Genetics Response letter 1.docx

    Attachment

    Submitted filename: Dubal et al Response to Reviewers.docx

    Attachment

    Submitted filename: PLOS Genetics Response to reviewers comments.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES